Exploring tuberculosis (TB) patient's adherence to treatment regimens and prevention programmes at a public healt site by Naidoo, Pamela
Exploring tuberculosis (TB) patient's adherence to treatment regimens and 
prevention programmes at a public health site 
by 
Pamela Naidoo 
Student Number: NDXP AMOO3 
Submitted to the University of Cape Town in partial fulfilment of the requirements 
for the degree of Master of Public Health 
Faculty of Health Sciences 
UNIVERSITY OF CAPE TOWN 
August 2006 
IL., 
  
 
 
 
 
 
 
 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
 
Published by the University of Cape Town (UCT) in terms 
of the non-exclusive license granted to UCT by the author. 
 
DECLARATION 
I, Pamela Naidoo, hereby declare that the work on which this dissertation is based is 
my original work (except where acknowledgements indicate otherwise) and that 
neither the whole work nor any part of it has been, is being, or is to be submitted for 
another degree in this or any other university. 
I empower the university to reproduce for the purpose of research either the whole or 
any portion of the contents in any manner whatsoever. 
2 
ACKNOWLEDGEMENTS 
I would like to thank my supervisor, Dr Judy Dick, for her invaluable guidance and 
constructive criticism during the research process and the writing up of the thesis. I 
am grateful to my co-supervisor, Dr Di Cooper, for her consistent support and 
valuable intellectual input. I also thank the National Research Foundation (NRF) and 
the University of the Western Cape for providing funding for this project. Finally, I 
thank my son, Sashelin and my daughter, Karmen, for helping me see the lighter side 
of life through their love and support. 
August 2006 
3 
Title page 
Declaration 
Acknowledgements 
Table of Contents 
Abstract 
Chapter One: Introduction 
1.1 Background 
TABLE OF CONTENTS 
1.2 Rationale for the study 
1.3 Aim and objectives of the study 
Chapter Two: Review of the Literature 
2.1 Adherence and non-adherence 
2.1.1 Introduction 
Pageoomber 
1 
2 
3 
4 
6 
9 
9 
14 
15 
17 
17 
17 
2.1.2 Environmental, social, cultural, disease and psychological factors 
influencing adherence and non-adherence 19 
2.1.3 Measuring non-adherence 27 
Chapter Three: Method 2& 
3.1 Study design 29 
3.2 Study setting 30 
3.3 Participants 31 
3.4 Procedure 32 
3.5 Analysis of the data 39 
Chapter Four: Findings 41 
4 
4.1 Introduction 41 
4.2 Findings: Phase one 44 
4.3 Findings: Phase two 62 
Chapter Five: Discussion 72 
5.1 Introduction 72 
5.2 The economic, social, cultural and psychological factors influencing 
adherence to TB medication 
5.3 Conclusion 
References 
75 
98 
100 
Table 4.1 Demographic profile, duration ofTB infective status, and the HIV status 
of study sample ( 42 
Figure 5.1 Factors influencmg adherence and non-adherence to 1B medication 
72 
Appendices 111 
Appendix One: Informed Consent Form (English and Xhosa versions) 
Appendix TWo: Background Information Questionnaire (English and Xhosa 
versions) 
Appendix Three: Interview guide 
5 
ABSTRACT 
TB has re-emerged as a health threat to societies worldwide and is, consequently, a 
public health issue. In sub-Saharan Africa there is a high prevalence of TB and South 
Africa, specifically, the Western Cape Province is said to have one of the highest 
prevalence figures in the world. While it is well established that TB is a disease of 
poverty and it is expected that the prevalence of the disease will remain high in 
communities where the cycle of poverty persists, it is important to explore other factors 
that may help to reduce prevalence and incidence despite the relatively under-resourced 
living conditions of patients. 
The aim of this study, therefore, was to explore the factors that contribute to TB 
patient's adherence to the Directly Observed Treatment Short-Course (DOTS) strategy 
and the factors that serve as barriers to adherence. The study was set in a historically 
disadvantaged township, KhayeIitsha, a sub-district of the City of Cape Town in the 
Western Cape Province. A qualitative, phenomenological research design, which is part 
of an ethnographic tradition, was used. Fifteen male and female participants between the 
ages of 18 to 57 years were ethically recruited through purposive sampling at Kuyasa, a 
Cape Town City Health primary care clinic. In phase one, in-depth individual 
interviews were conducted in Xhosa, a predominantly used African language in the 
Western Cape. Issues around the core cognitive and social concepts linked to the study 
inquiry, namely, illness challenges, quality of health care received, adherence to the 
treatment regimen, level of awareness about the risk and dangers of infecting others, and 
reasons for participation or non-participation in voluntary counselling and testing (VCf) 
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for the human immunodeficiency virus (HI\,) were probed~ In the second phase, a focus 
group was conducted with the team of health care practitioners directly involved in the 
administration and management ofTB treatment at the Kuyasa clinic, to ascertain their 
responses to the feedback given to them about the results obtained from the 15 
individual interviews conducted. The interviews and the focus group discussion were 
tape recorded and transcribed for the purposes of the data analysis. 
Theoretically this study is underpinned by a relativist perspective, which is one in which 
the value of theories and knowledge is determined by historical and cultural factors that 
are dynamic and change over time (Abraham, 2004), A hermeneutical 
phenomenological approach, which may be located within a relativist paradigm, was 
used to understand how the life circumstances and experiences of the participants 
influenced their choice to adhere to treatment for TB. 
A qualitative data analysis method, which organizes phenomenological data as 
suggested by Moustakis (1994), was used to develop themes from the responses of the 
participants in phase one of the study and from the health care practitioners in phase 
two. Adherence to TB treatment in the public health sector must be understood within 
the individual characteristics of the TB patient including their social and economic 
resources, and the health care setting. The results indicated that six of the 15 participants 
were co-infected with HIV and no participants were 100 % adherent to TB treatment. 
Instead, a pattern of adherence and non-adherence to treatment ro-existed. In general the 
participants were knowledgeable about the disease, its infectious nature, and the 
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effectiveness of drug therapy but nevertheless admitted to periods of non-adherence. 
Factors found to influence patterns of adherence either directly or indirectly were: social 
and economic resources prior to the onset ofTB and during the course of the disease; the 
causal attributions assigned to TB; the social, cultural, economic, disease-related and 
psychological challenges faced as a consequence of having TB; quality of health care 
received; use of the 1raditional healing system; and the participants' HIV status. Factors 
that appear to be strongly associated with periods of non-adherence include poverty, 
HIV co-infection, stigma and unsupportive social and work environments. The 
prevalence of helplessness, hopelessness and depression among the participants of this 
study is possibly one of the most significant psychological contributors of non-
adherence to TB treatment. The health care practitioners concurred with the findings 
from phase one but also provided significant additional input about the advantages and 
disadvantages of the World Health Organization's (WHO) recommended direcdy-
observed treatment short-course (DOTS) strategy, and made suggestions about how to 
improve the health service to TB patients. 
The findings will be conveyed to the most important stakeholder, which is the 
management team at the Cape Town City Health Department. The following 
recommendations regarding the implementation of the existing TB treatment and 
prevention programme will be made: the need for greater commitment to patient-and 
community-centred' health promotion strategies, support groups for 1B patients infected 
for the first time and for those with HN and 1B co-infection, and a more comprehensive 
community-based programme using a team of health professionals. 
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1.1 Background 
CHAPTER ONE 
INTRODUCTION 
In 1993 the World Health Organization (WHO) declared tuberculosis (TB) as a global 
health emergency. Since this declaration by the WHO, there has been a serious effort to 
contain the TB epidemic (WHO, 1996,2001,2002). Yet this infectious disease remains 
a health threat and although it is a completely curable disease, it is the leading cause of 
young adult deaths (WHO, 2002). The spread of TB continues worldwide despite the 
widely available internationally recognized Directly Observed Treatment, Short-course 
(DOTS) strategy to control the epidemic (WHO, 2001). 
TB is classified as a communicable disease. According to Beaglehole, Bonita and 
Kjellstrom (1993), a communicable or infectious disease is "an illness caused by 
transmission of a specific infectious agent or its toxic products from an infected person 
or animal to a susceptible host, either directly or indirectly (p 97). Berkow, Beers, and 
Fletcher (1997) provide a medically contextualized understanding of the disease. TB, 
they state "is a contagious, potentially fatal infection caused by the airborne bacterium 
Mycobacterium tuberculosis, M. hoViS, or M amcanum" (p 968). TB is spread when 
infected people cough, sneeze, or speak and those individuals who are exposed long 
enough to the infected person may breathe in bacteria and become infected. 
To understand the pattern of TB infection over time, it is important to locate the disease 
in a social and historical context. Packard (1989) provides an informative and critical 
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account of the development of the disease in Europe and America and how, in his 
opinion, the disease was transported to Africa during the period of colonization. At the 
end of the nineteenth century, through the process of colonization, industrialization 
expanded into the so-called "third world", including Africa. The increase and rapid 
spread ofTB, commonly known as the "great white plague" in the late eighteenth to the 
early twentieth century in Europe and America caused high mortality rates, occurred at 
the beginning of the industrial revolution. A great number of people migrated to the 
cities to engage in paid employment but often lived in overcrowded conditions marked 
by squalor. TB has also been referred to as the "consumption of the poor" (Fanner, 
1999). Farmer (1999) emphasizes the role of poverty in the spread of the disease and 
states that throughout history TB has been more prevalent among the poor. The decline 
in TB mortality in America and Europe is related to improved living and working 
conditions from the mid-nineteenth century (packard, 1989; Fanner, 1999). 
TB is completely curable through the intake of a strict anti-TB drug treatment regimen. 
The DOTS strategy, introduced in 1991 by the World Health Organization (WHO), is an 
inexpensive strategy that could prevent millions ofTB cases and deaths. DOTS consists 
of five key elements: (1) government commitment to sustained TB control; (2) deteCtion 
ofTB cases through sputum smear microscopy among people with symptoms; (3) 
regular and uninterrupted supply of high -quality anti-TB drugS; (4) six to eight months 
of regularly supervised treatment (including direct observation of drug-taking for at least 
the first two months); and (5) reporting systems to monitor treatment progress and 
programme performance 
<http://www.who.intlmediacentrelfactsheetslfsl04/en1index.html). 
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Once patients with infectious TB (bacilli visible in a sputum smear) have been 
identified using microscopy services, health and community workers or trained 
volunteers observe patients swallowing the fuji course of the correct dosage of anti-TB 
medicines. The most common anti-TB medicines are isoniazid, rifampicin, 
pyrazinamide, streptomycin and ethambutol. 
Sputum smear testing is repeated after two months to check the patient's progress, and 
again at the end of treatment. The recording and reporting system ensures that the 
patient's progress can be followed throughout treatment. It also allows assessment of the 
proportion of patients who are successfully treated, giving an indication of the quality of 
the programme. The DOTS strategy produces cure rates of up to 95% even in the 
poorest countries lhttp://www.who.intlmediacentre/factsbeetslfsl04/enlindex.html). 
In developing countries especially the sub-Saharan region including South Africa (SA), 
where poverty is widespread, there is a high prevalence of infectious diseases, such as 
TB. About eight million people become sick with TB each year and in sub-Saharan 
Africa, about two million cases are reported (WHO, 2002). The WHO ranks Sou1h 
Africa as having the lOth highest TB rate in the world with a low treatment success rate 
of 68% in 2003. In 1999, SA registered a total of 118 686 newly diagnosed pulmonary 
TB cases. Of these only 60.3% of the new smear positive cases were eventually cured 
and 17.2% interrupted their treatment (WHO, 1997). At this point the cure rate was well 
below the WHO target for cure rate. WHO targets, ratified by the World Health 
Assembly in 1991 were to detect 700A. of new infectious TB cases and to cure 85% of 
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those detected by 2005. While many coun1ries have met these global targets, controlling 
the spread of TB remains a challenge, worldwide. 
South Africa has one of the worst TB epidemics in the world, with disease rates double 
that found in other developing countries (Fourie, 2005). The role of poverty in the 
spread of TB is well illustrated in South Africa. Despite the advent of a democracy in 
South Africa in 1994, the quality of life of the average South African, particularly 
people who have been previously disadvantaged remains relatively poor, making them 
more susceptible to ill-health. In a recent edition of the Sunday Times, reporter 
Ntshingila (2006) published the findings of research conducted by "Eigbty20", described 
as a "financial think-tank", about the poverty status in South Africa. It was found that 
more than 15% of South Africa's 46.9 million people live well below the accepted 
poverty line of one United States Dollar (1 USD). 
The HIV and acquired immunodeficiency syndrome (AIDS) pandemic has, 
unfortunately, exacerbated the public health dimensions ofTB because many individuals 
are co-infected with TB. and HIV and AIDS (WHO, 1996). Worldwide, an estimated 
one-third of the 40 million people living with HIV IAIDS are co-infected with TB, and 
up to thirty-five million people worldwide could die of TB over the next two decades 
unless greater action is taken to treat and prevent the disease. TB speeds up the progress 
ofHIV and AIDS and vice versa.. TB is the leading cause of death among people who 
are HIV -positive and accounts for about 13% of AIDS-related deaths worldwide 
lhtto:/lwww.globalhealthreport.ing.orgltb.asp.). 
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The importance of adherence behaviour of TB infected individuals 
In a condition such as TB a relatively strict adherence to the treatment programme is 
necessary for the patient to be cured. Given the high prevalence and incidence of TB in 
sub-Saharan Africa, including South Africa and the urgent need to contain the disease 
and prevent this life-threatening disease from spreading, it is essential that that the 
aftlicted individuals heed the advice and follow the treatment plan as suggested by 
health care practitioners. 
A possible explanation for the low cure rates for TB in South Africa is poor adherence to 
the treatment programmes by the infected individuals. In addition, inconsistent 
adherence to the anti· TB prescribed drug regimens may lead to multiple drug resistance 
making it difficult to achieve high cure rates. Farmer (1999) argues that multiple.dfug 
resistant TB (MDRTB) is more prevalent among the poor and should, therefore, be 
understood as a "biosocial" phenomenon. The emergence ofMDRTB, according to 
Farmer (1999), is similar to the spread ofHIV among certain populations because it is 
shaped by political, economic and cultural processes. If these barriers or issues of 
"structural violence" are not addressed by the health authorities and governments, the 
cost of health care to the state increases because more expensive drugs are needed to 
treat individuals who develop MDRTB (Farmer, 1999). The cost of treating MDRTB is 
100 times as much as the cost of curing a TB patient infected with drug--sensitive 
bacteria (Fourie, 1995). Given the structural barriers that individuals infected with TB 
face, it is critical, therefore, to understand what factors influence the willingness or the 
13 
ability of patients to adhere to treatment and prevention programmes and to utilize this 
understanding to change the affected individual's behaviour to encourage higher 
adherence rates and to modify the existing programmes and/or devise new ones. 
1.2 RatioDale for this study 
TB is a serious public health concern given that in SA there was an estimated 419 per 
100 000 of the total population infected with the disease in 1997 (Fourie, 2005). TB 
cases have increased from 349 per 100 000 people in the year 2000 to 550 in 2003, with 
the worst affected provinces being the Northern Cape, Western Cape and KwaZulu-
Natal (http://allafrica.com). In the Cape region, the actual registration reports to the 
National Department of Health indicated smear positive rates as 285 per 100 000 of the 
total population for the Western Cape, 300 for the Eastern Cape, and 328 for the 
Northern Cape (Fourie, 2005). Although there is a reduction in the rate ofTB in the 
Cape, until recently the Western Cape was regarded as one of the regions with the 
highest rates of the disease in the world (Fourie, 2005). This study was conducted in the 
Western Cape. 
In keeping with the United Nations Millennium Development Goals, which includes 
reducing TB prevalence and death rates by half by 2015, it is vital to examine the factors 
that may help alleviate the burden ofTB as a disease. This means that those patients who 
are already infected and present themselves for treatment must be willing to adhere to 
their treatment regimen to improve their health status, and in doing so will prevent 
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others from being infected. As already mentioned, in a condition such as TB a relatively 
strict adherence to the anti-TB treatment programme is essential for the patient to be 
cured. 
Although this study is located within the discipline of public health, it interfaces with 
health psychology and public health because it explores the psychological factors that 
are pertinent to TB patient's adherence to treatment regimens and prevention 
programmes. Interfacing the fields of health psychology and public health is one way of 
achieving in-depth knowledge of both individual factors and factors external to the 
individual that impact adherence to anti-TB treatment. The term adherence implicitly 
implies that an individual has to be personally invested and motivated in cooperating 
with health care practitioners to follow and complete a treatment and/or prevention 
programme. 
1.3 AiID aDd objectives of the study 
The aim and objectives of the study were achieved through the use of a qualitative 
research design. An interview guide (see Appendix Three) was prepared to ascertain, 
during the individual interviews, the factors that promote and hinder adherence to anti-
TB treatment in an under-privileged group ofTB patients attending a public health 
centre in Khayelitsha, a township in the Western Cape Province of South Africa. 
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The primary aim of the study was to explore individual factors and those factors external 
to the patient with TB, that contribute to his or her adherence to Directly Observed 
Treatment (DOn, with the purpose of empowering patients, improving health services 
and ultimately, increasing cure rates. 
Questions for the interview guide were developed from the existing literature on the 
factors found to influence adherence and non-adherence. The types of questions asked 
helped to meet the objectives of the study, which were: 
(1) To ascertain the patient's knowledge of the disease. 
(2) To explore the patient's perception of the baniers or facilitating factors to adherence 
to TB treatment. 
(3) To explore the patient's perception of the quality of health care they receive. 
(4) To explore the reasons for agreeing to or refusing voluntary counselling and testing 
(YCn for the HI virus. 
A review of the literature on the factors pertinent to an individual's adherence to the 
treatment and health-promotive programmes recommended by health care practitioners 
is presented in Chapter Two. 
16 
CHAPTER TWO 
REVIEW OF THE LITERATURE 
2.1 Adherence and non-adherence 
2.1.1 Introduction 
Adherence to treatment regimens is critical in chronic diseases, particularly those that 
are potentially fatal and communicable, such as TB. Non-adherence, especially to 
medical treatment, is detrimental to patients because they may develop serious 
complications from their conditions. According to the WHO (2003), "Poor adherence is 
the primary reason for the suboptimal clinical benefit. It causes medical and 
psychosocial complications of the disease, reduces patients' quality oftife and wastes 
health care resources" (p 25). Despite the information that patients have about the 
consequences of not cooperating with the treatment plan suggested by the health care 
professionals and the time that health professionals invest in attempting to improve the 
quality of life of these patients by addressing their health care needs, a high percentage 
of people in health-related treatment programmes do not comply (Becker & Maiman, 
1980; DiMatteo & DiNicola, 1982; Kaplan & Simon, 1990; Trostle, 1997). 
Adherence and non-adherence: Developed and developing cQUntries 
In developed countries there is a significant amount of literature on the various factors 
influencing behavioural and medical adherence and non-adherence in preventative, 
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maintenance and promotive health amongst individuals. A range of environmental, social 
and organizational, cultural, disease, treatment, and psychological factors associated with 
non-adherence have been identified (DiMatteo & DiNicola, 1982; Meichenbaum & Turk, 
1987; Marks, Murray, Evans, & Willig, 2000). One may assume that individuals in 
developed countries are better re-resourced, socially, educationally and economically, 
and that largely individuals may adhere or not adhere to treatment regimens based on an 
informed personal choice. Marginalized groups of people, such as the poor and the 
homeless in developed countries, however, may face challenges which prevent them from 
adhering to treatment and prevention programmes. While similar factors influencing 
adherence may be operational in developing countries, the contextual features of these 
countries must be taken into account. In a country such as South Africa, the majority of 
citizens are still disadvantaged, which implies that there are certain economic, social, and 
cultural factors that may overwhelm the potential an individual has for decision-making 
about important life events, including health-related decisions. 
In reviewing the literature on behavioural and medical adherence and non-adherence to 
treatment and prevention programmes, it is clear that it is far too simplistic to make broad 
comparisons between the health behaviours of individuals in developed countries and 
those in developing countries. Poor adherence rates are reported worldwide (Sackett & 
Snow, 1979) despite the fact that in some countries there is a better quality of life, 
overall. In a synthesis of qualitative studies on individual's resistance to medicines, 
Pound, Britten, Morgan, Yardley, Pope, Daker-White and Campbell (2005) found that 
individual's were very reluctant to take medicine and prefer to take as little as possible. 
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In the next section a more detailed analysis of the factors that have an impact on whether 
individuals afflicted with a disease condition will cooperate with the suggested treatment 
plan of the health care practitioner. Applying this existing body of knowledge to the 
South African health care context in the face of the national health priorities, namely TB. 
mv and AIDS. and malaria will help to reduce the burden of these diseases and improve 
the quality oftife of individuals. Within the context of this study, exploring the 
environmental, social and psychological factors that may improve or impede a TB 
patient's ability to adhere to treatment and prevention programmes wilJ ultimately 
improve cure rates. 
2.1.2 Environmental. social, cultural, disease and psychological factors influencing 
adherence and non-adherence 
Errvironmental factors 
Often environmental, social and cultural factors that are external to the individual may 
pose as barriers to adherence. Insufficient knowledge about the nature of a disease and 
the consequences of being afllicted may lead people to underestimate the importance of 
engaging in health-promotive and preventative behaviours; one of which is to cooperate 
with treatment and prevention programmes in order to maintain ones health status. The 
media has played a significant role in educating the public about the devastating 
consequences of becoming mv positive, for example. through engaging in risky sexual 
behaviours; and the causative relationship between smoking and lung cancer. HN and 
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AIDS, and lung cancer are but only two conditions, amongst several, that are life-style 
related. 
The cha1lenge for public hea1th specia1ists and others working in the interest of 
promoting hea1thier nations is that often, despite the health messages that individuals gain 
through various sources they do not adhere, or in some instances are not able to adhere, to 
the behavioural and medica1 recommendations to live a reasonable quality of life, which 
includes good physica1 and mentaJ hea1th. In a country such as South Africa while serious 
attempts are being made to provide health messages to the public through various 
agencies, such as TV, the newspapers, radio, billboards and so on, these messages are not 
accessible to all. Many individuals who Jive in rural areas or in abject poverty do not 
have the resources that enable them to become empowered through the informal 
education provided by the various agencies mentioned. Health messages are unlikely to 
reach those that are at the greatest health risk, such as the poor and the uneducated 
(DiMatteo & DiNicola, 1982). This of course means that the vicious cycle of individua1s 
infecting each other through a lack of health knowledge will perhaps continue. 
Another factor associated with poor adherence is health literacy (Sullivan, Dukes, Harris, 
& Dittus, 1995). Often patients do not understand the treatment instructions and 
suggestions given to them by the health service providers. Lower levels of education are 
expected to be associated with poor health literacy. In a study conducted by William, 
Parker, Baker, Parikh, Pitkin, Coates, and Nurss (1995) among a sample of patients of 
low socio-economic status, it was found that 42% were unable to understand what the 
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treatment direction for taking medication, "on an empty stomach", meant and at least a 
quarter of the patients were unable to understand information about their follow-up 
appointment. The relationship between poor adherence and health literacy may contribute 
towards lower cure rates of TB in South Africa, where a large proportion of individuals 
attending public health sites are disadvantaged and have minimal levels of formal 
education. 
The quality of the communication between the patients and the health service practitioner 
may also pose a barrier to adherence. The way the patient perceives the attitude of the 
health service provider also affects adherence. Adherence is usually better when the 
health practitioner displays the capacity to be human, that is, the practitioner is warm, 
caring, listens intently not only to the reporting of the patients symptoms but also to what 
is happening in the patients social life. DiNicola and DiMatteo (1982) found that patients 
are more compliant if their doctor is warm, caring, friendly and interested. A person-
centred approach by the health care practitioner enhances adherence as compared to an 
authoritarian style, which appears to give the practitioner too much control in the patient-
practitioner relationship. Patients' are less likely to adhere to treatment regimens if they 
perceive the doctor to be judgemental, infantilizes himlher by 'scolding', and conveys the 
message that the patient is in a powerless position relative to the doctor (Roberson, 1992; 
Rogers, Day, Williams, Randall, Wood, Healy, & BentalI, 1998). 
Another factor affecting adherence is the patient's perception of the nature and quality of 
the health care setting. If patients perceive that the health care setting has good 
21 
infrastructure then it is more likely that they will comply with treatment. Waiting times, 
availability of health care staff, perceived efficacy of drugs, perceived competence of 
health care staff and so on, contribute to the overall infrastructure of a facility 
(Meichenbaum & Turk, 1987). 
An individual's limited economic resources may also influence adherence patterns 
(Farmer, 1999). This is especially true in communities that are served by the public health 
sector. Often patients have limited resources with many competing demands and often 
cannot meet the cost of their individual and their family's health care needs. The life 
conditions and quality of life of these individuals were compromised prior to the onset of 
the disease and their socio-economic status is worsened as a consequence of having an 
illness condition. Brainard, Hyslop, Mera, and Churchill (1997) found in an outpatient 
treatment facility for TB, the only predictor of poor compliance was homelessness. This 
fmding confrrms the strong relationship between adverse living conditions and the 
motivation (or the lack of it) to engage in health promoting behaviours, such as adhering 
to treatment programmes. 
Social factors 
Adherence to treatment programmes that require the person affected by the illness 
condition to be disciplined and consistent about fo]]owing the suggested behavioural and 
medical (including drug therapy) therapy appears to be more successful with good social 
support from family and friends (Berg & Lipson, 1999; Rhodes, Martin, & Taunton, 
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2001). Family and friends not only provide relevant health information to the patient but 
also encourage the patient to cooperate with and follow through on the recommendations 
of the health care practitioners. A higher rate of adherence to appointments was found in 
chronically ill patients with good social support (Tanner & Feldman, 1997). Compliance 
to a recommended diet was found among men whose wives were very supportive as 
opposed to wives that offered little support (Bovbjerg, McCann, Brief, FoJlette, Retzlaff, 
Dowdy, Walden, & Knopp, 1995). On the other hand, poor compliance to medical 
treatment was found in individuals from unstable families (Bender, Milgram, & Rand, 
1997). 
Cultural Factors 
Cultural and religious factors may also affect the way and the extent to which an 
individual cooperates with a treatment or prevention programme (Kato & Mann, 1996; 
Nail & Speilberg, 1967). An individual's behaviour is often guided by the cultural 
context within which he/she lives and may, therefore, not adhere to all or some 
components of the treatment programme for fear of being rejected by significant others. 
Additionally, the individual may not be able to endure the guilty feelings for going 
against the grain of expected behaviours associated with health care in his/her 
community. 
The relationship between culture and health is complex. Culture shapes all aspects of our 
behaviour, including, for example, the type of food one eats; and when, where and how 
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certain ritualistic acts may be performed. Of course, most cultural prescriptions are 
underpinned by a sense of meaningfulness within various groups of people. Difficulties 
arise when certain disease conditions require as part of a treatment plan, for example, a 
restricted diet or the use of drugs that may contain substances that are taboo, such as 
alcohol. }(agee (2005) found that in a sample of disadvantaged hypertensive and diabetic 
patients in South Africa, prescribed treatment regimens affected family functioning. 
Participants in his study reported that the prescribed change in their diet set them apart 
from their families. 
Finally. the use of alternate or indigenous healing methods may also influence the way in 
which an individual complies with treatment Pound et at (2005) report in an article based 
on a review of qualitative studies on resistance to medicine taking. the widespread use of 
"non-pharmacological" treatments. In Africa and Asia there is widespread use of 
culturally endorsed treatment methods that has been used for centuries. Consulting with a 
traditional healer in times of ill-health is commonly reported in South Africa (Bengu, 
1989). The Ayurvedic system of health and healing. which originated in India, is also 
extensively used. It is estimated that 7()oA, of the population in India and indeed many 
people throughout the world use Ayurveda as a treatment method of choice (Schober, 
1997). Traditional medicines given to patients may not always, however. compliment the 
prescribed mainstream treatment methods. 
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Psychological Factors: Patient characteristics 
Efforts have been made to identify the "non-compliant" personality. The evidence for the 
relationship between personality characteristics and compliance among patients is 
unconvincing. There appears to be no consistent relationship between age, sex, marital 
status, education, the number of people in a household, social class and compliance 
(Hulk&, 1979). The relationships between adherence, age and gender are fairly complex. 
Depending on the type of illness, the nature of the illness, the illness course, and the 
adherence regimen, studies show that treatment cooperation can either increase or 
decrease with age; and that men and women may adhere differently to recommendations 
(Brannon & Feist, 2000). 
Certain sub-groups of people have been found to be more non-compliant to medically 
prescribed treatment. There are sub-groups of ''non-compliers'' who are described as 
being more dependent, more irrational, and tend to rebel against the authority of the 
physician (Gillum & Barsky, 1974; Christensen, Moran, & Wiebe, 1999). Individuals 
who have very low or very high levels of anxiety also seem to represent another sub-
group of , 'non -compliers" (Ley & Spelman, 1961). Patients who are low in anxiety may 
not remember what the health care practitioner has recommended and those high in 
anxiety may be so overwhelmed by their mood state that they cannot process what was 
said by the health care practitioner. 
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According to Marks et al (2000) evidence suggests that the more the prescribed 
medication is congruent with the patienf s belief systems, the more likely they are to 
comply with the suggested treatment. Social cognitive models, in particular the Health 
Belief Model (HBM) (Rosenstock, 1974), have been popularly used to explain the 
relationship between a patient's health beliefs and compliance. The HBM proposes that 
there are two major factors that underpin whether an individual performs a particular 
health behaviour. These factors are: (a) the degree to which the disease is perceived as 
threatening, and (b) the degree to which the health behaviour is believed to be effective in 
reducing the risk of a negative health outcome. According to the HBM the degree to 
which an individual complies with treatment programmes rest on the perceived disease 
severity, susceptibility to the disease, benefits of the treatment recommended and barriers 
to taking the treatment. Support for the HBM seems to depend on the type of disease 
condition an individual has. Masek (1982), for example, found that the more patient's 
perceived their disease to be serious, the more likely they are to adhere to treatment 
recommendations. Glasgow, Hampson, Strycker, and Ruggiero (1997), however, did not 
find perceived seriousness of diabetes predictive of adherence. 
Disease factors 
Disease characteristics, such as the severity of the disease and whether or not the patient 
is symptomatic have been found to be associated with treatment compliance (Marks et ai, 
2000). Individuals with chronic diseases, which are not symptomatic, or are in remission, 
are less likely to adhere to treatment regimens (Miller, 1997). Individuals afflicted with a 
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disease, which has a poor prognosis and is tenninal, such as cancer, may be less likely to 
comply as they may not see compliance as making a difference to their disease outcome 
(Dolgin, Katz, Doctors, &, Siegal, 1986). 
2.1.3 Measuring non-adherence 
It is rather difficult to measure non-adherence because both patients and health care 
providers appear to provide inaccurate estimates. According to Friedman (2002), there 
appears to be a lower rate of adherence if measured objectively and a higher rate if self-
reports are taken from patients' or the health-service provider. Patients tend to over-
estimate their compliance to treatment regimens and health care practitioners, such as 
doctors and nurse practitioners, often do not detect lower rates of compliance. Patients 
do not often report their non-adherence or inconsistent adherence for fear of being 
reprimanded by the health care practitioner and therefore provide responses expected of 
them. 
According to Friedman (2002) more objective measures of adherence to medication, 
include checking medical records to see if patients are attending fullow-up medical 
visits, checking pharmacy records, and pill counts. Of course none of these measures are 
fool proof because patient's may still not be taking medication despite the pharmacy 
records showing that they have collected their drugs and the pill counts indicating that 
they have indeed taken their medication. The best objective measure of compliance to 
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drug taking is a direct measure of the medication in the patient's body by means of a 
tracer or the medications metabolic by-product (through urine testing). 
In this study, the measure of non-adherence is relatively uncomplicated because the TB 
treatment programme requires that the individual on the programme visit the health care 
setting consistently for a specified period of time to receive the anti-TB drugs under the 
direct supervision of the nurse practitioner(s). Failure by the TB patient on TB 
medication to attend the health clinic as prescribed by the health service providers would 
constitute non-cooperation to the treatment. The WHO DOTS strategy for TB was 
discussed in Chapter One, section 1.1. 
The literature review shows that adherence and non-adherence to treatment and 
prevention programmes should be understood from both the patient's and the health care 
practitioner's perspectives. Patients in developing and developed countries using public 
health services are usually marginalized individuals from the under-privileged class and 
are, consequently, severely under-resourced and not able to control the factors that may 
influence whether they are able to co-operate with the treatment recommended and/or 
provided by the health care practitioners. The complex array of factors that contribute to 
adherence behaviour must, therefore, ultimately be understood from a patient-centred 
approach, which is the approach used in this study. 
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3.1 Study Design 
CHAPTER THREE 
METHOD 
Methodologically, this qualitative study is framed within phenomenology, which is 
considered to be an ethnographic approach (payne, 2004). Colman (2001) describes 
phenomenology as "A philosophical method of inquiry, introduced in 1901 by Edmund 
Husserl, that concentrates on the detailed description of conscious experience while 
suspending or bracketing all the preconceptions, interpretations, and explanations" (p 
533). In the human sciences accessing meaning must be done through examining and 
exploring individual's perceptions, cognitions, and language. Consequently, concrete 
descriptions of the lived experience of individual's become an important source of data 
(Von Eckartsberg in Vaile, 1998). In this study the lived experience of the participants 
who were diagnosed with TB was the main reference point in attempting to understand 
why some patients adhere to TB medication and others do not. The subjective 
experience articulated through the participant's own 'voice' became the study data. In-
depth individual interviews, the focus group and field notes were used to collect data in 
the study. 
In the first phase of the study, in-depth individual interviews of the participants were 
conducted. In the second phase of the study, immediately following feedback to the 
health care practitioners of the findings of the first phase of the study, a focus group was 
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conducted to ascertain the level of receptivity and understanding of the various themes 
that emerged from the data analysis of the in-depth interviews. 
3.2 Study setting 
The study was conducted in Khayelitsha, a sub-district in the Cape Town Metro Region 
of the Western Cape Province. Khayelitsha, was established in 1983 during the 
Nationalist Party's apartheid rule, and is a "large peri-urban" area situated 32km from 
central Cape Town (Cooper, 1995). The 2001 population census estimated that the City 
of Cape Town had 2 893246 people and the Western Cape had 4.5 million people of 
which 51.5% were females (Western Cape Population Profile, 2001). The population of 
Khayelitsha is about 340 000, made up of predominantly black South Africans (Western 
Cape Population Profile, 2001). The area was serioUsly under-funded during apartheid 
rule, and despite democratic governance in South Africa since 1994, is still marked by 
poverty, high rates of unemployment and poor infra-structure. A mixture offormal and 
informal housing, and of formal and informal trading, is characteristic ofKhayelitsha. It 
is indeed visible that there are "pockets" of areas that are better serviced than others with 
respect to public transportation, public health sites, local government maintenance of 
public spaces, businesses, and so on. 
Public health services in Khayelitsha are provided by the Provincial Government of the 
Western Cape (pGWC) and Cape Town City Health. The study was confmed to only one 
City Health clinic, namely the Kuyasa clinic, which is one of several City Health clinics 
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in Khayelitsha. The City Health management requested that the study is conducted in the 
sub-district ofKhayelitsha because of the low cure rate for TB in this area, as compared 
to the other seven sub-districts making up the Metro Region. In the 2nd quarter of 2005, 
there was a 51 % cure and success rate for new smear positive cases for TB in Khayelitsha 
and a cure rate of 62% to 80% in the other seven sub-districts for the same period 
(Azevedo, 2006). 
3.3 Participants 
In phase one of the study, medically confirmed adult male and female registered TB 
patients that tested smear positive and who were already enrolled into treatment 
programme at the clinic were eligible to participate. Purposive sampling techniques 
(Bless & Higson-Smith, 1995) were used to recruit respondents. Saturation of data 
occurred with a sample of 15 respondents. Participants were carefully or 'purposively' 
selected to ensure that there was a reasonable 'spread' or range of patients with respect to 
age, sex, and consistent, inconsistent or failed attendance at the clinic for treatment The 
participants were Xhosa-speaking, which is the predominant language used in the area of 
Khayelitsha and generally by black Africans in the province of the Western Cape. 
Patients with a psychotic disorder were excluded from the study. TB patients on 
treatment regimens for other co-conditions, such as HIV and AIDS, were also excluded. 
Only those TB patients who were exclusively on the TB treatment programme were 
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included in the study because of the study's focus on the factors that influence adherence: 
specifically to this treatment programme. 
In phase two of the study, health care practitioners involved in the management ofTB at 
the Kuyasa clinic were invited to participate. The staff that participated in this phase of 
the study was engaged in the research process in the most ethical way possible. Special 
emphasis was placed on ensuring that the health care workers understood and trusted the 
fact that their participation in the project will not adversely affect the quality and the 
nature of their relationship with their seniors (health managers). This was done through 
open and transparent communication with the TB health care team at Kuyasa from the 
planning phase of the project until its completion. 
3.4 Procedure 
During the preparatory stage of the first phase of the study, prior to the selection of the 
participants, the health care practitioners that assisted in selecting the participants were 
advised by the principal investigator (PI) and the research assistant on what the eligibility 
and exclusion criteria were. The health practitioners were also requested to select a range 
of registered TB patients, i.e. young and older adult male and female patients on TB 
treatment who attended the clinic consistently; and young and older adult male and 
female patients on TB treatment who were inconsistent and irregular in their attendance. 
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The TB patients who participated in the study and who attended the clinic consistently 
were interviewed by the research assistant at the clinic in a specially designated room. 
The participants who were on TB treatment but were not attending the clinic consistently 
or had not attended the clinic for some time were interviewed in their homes or other 
places of abode. In some instances arrangements were made to interview them at the 
Kuyasa clinic. Access to these patients, who were potential participants for the study, was 
possible because the research assistant accompanied the community TB workers on their 
field visits. 
The community TB workers were responsible for trying to locate the registered patients 
who were not adhering consistently to the TB treatment programme and to re-emphasize 
to them the importance of attending the clinic for treatment. In addition, the community 
workers are able to ascertain the possible barriers experienced by those TB patients not 
adhering to treatment and assist the patient to overcome them where possible. The 
services provided by the community worker is one component of the regular health 
service rendered by the clinic as part of the DOTS strategy. Of course in some cases it is 
found that the patients listed on the clinic records as not adhering to the programme, have 
in fact passed away. Their death could be a consequence of poor adherence to TB 
treatment, or from being co-infected with other disease conditions, such as AIDS, which 
could have led to their premature death. 
Once a potential participant was identified and recruited for the study and if they agreed 
to participate, they signed an informed consent form in Xhosa (see Appendix One), 
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which included their right to withdraw from the study at any time. During the period of 
'briefing' (Kvale, 1996) it was ensured that they understood the various aspects of their 
rights', and the researcher's obligations as stated in the infonned consent fonn. In the pre-
interview stage, the research assistant administered a short biographical questionnaire just 
prior to conducting the interview to obtain background demographic infonnation (see 
Appendix Two). In addition a few semi-structured questions were asked in order to 
contextualize the life circumstances of each of the participants. The pre-interview phase 
served two purposes. Firstly, it facilitated in a non-threatening way, the development of 
rapport between the participant and the interviewer and allowed for the necessary 
psychological distancing on initial contact. Secondly, the characteristics of the data 
collected in the pre-interview phase, such as the demographic information, was common 
to all the participants. Consequently, each participant's subjective experience of the TB 
treatment programme and the difficulties they encounter in adhering to TB medication 
was framed within their individual characteristics, such as age, sex, marital/partnership 
status, and so on. The in-depth interview, conducted in Xhosa, followed. 
The iB· dept" mtervin 
The semi-structured in-depth interviews were conducted by a trained research assistant 
who is also a clinical psychologist well trained in qualitative interviewing techniques. 
Each of the 15 participants was interviewed for one session for the duration of between 
90 and 120 minutes. A set of guiding questions was developed for the interview. The 
questions were as follows: (1) Tell me about the time you were first told that you have 
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TB. How do you think you got infected? (2) Tell me how much you know about TB?; 
(3) What was happening in your life at the time you were diagnosed with TB?; (4) What 
is your experience of being a person with TB?; (5) What is your experience of taking the 
treatment that the nurses in the clinic give you? Have you been able to take your 
treatment exactly the way the nurses have advised you to? Are you getting advice and/or 
treattnent from anyone else besides the nurses and doctors that treat you in the clinic? 
and (6) Have you been asked by the nurses whether you would like to have an HIV test? 
Would you mind telling me if you agreed to have the test? 
The questions were framed within a time sequence, i.e. participant's experience of their 
disease condition was explored from just prior to being diagnosed with TB until the point 
that the interview was conducted. Interviews were tape recorded and later transcribed for 
analysis. The interview data was translated into English for the following reasons: Firstly, 
it allowed the PI to make sense of the data because she is not proficient in Xhosa, and 
secondly it facilitates the dissemination of the study findings to a wider audience. 
The interview process was guided by Moustalds' (1994) concept of the Epoche, which 
involves "setting aside pre judgements and opening the research interview with an 
unbiased, receptive presence" (p 180). This meant that the interviewer tried to maintain a 
non-judgemental presence throughout the interview and did not allow her prior 
knowledge about the participant, influence the interviewing process. The participant's 
'voice' was of paramount importance and the interviewer was, in a sense, also guided by 
the participant's responses in deciding when and how to probe the emergent themes. This 
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process was a completely non-invasive one. A period of debriefing followed the 
interview (Kvale, 1996), after the tape recorder was switched off, to allow the 
participants to express any emotional conflicts or anxieties they had that may have arisen 
out of their disclosure about their lived experience of being infected with TB, and about 
other significant life events, such as discovering their HIV positive status. 
To maintain a high ethical standard the tapes have been locked in a cabinet that only the 
PI has access to in order to ensure confidentiality of the participant's identity and 
responses. The tapes are not marked with the patients names. 
Focus group 
A single focus group was conducted, in English, with three health care practitioners and 
one supporting TB health worker assistant involved in the management ofTB at the 
Kuyasa health clinic. The PI acted in the capacity of the focus group facilitator and the 
research assistant was the co-facilitator. All the members of the focus group were women 
and comprised of the nurse manager, the sister-in charge, a professional nurse, and a TB 
health worker assistant. There was one male in the health worker team who was, 
unfortunately, unavailable on the day the focus group was conducted. The duration of the 
focus group was 120 minutes. The focus group discussion was tape recorded and later 
transcribed for analysis. These tapes are also locked in a cabinet to ensure the focus group 
member's identities are protected and their responses are kept confidential. Only the PI 
has had access to the tapes since the transcriptions were done. 
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Using a focus group is one way of generating qualitative data. The choice of using a 
focus group as a data collection technique, instead of individual interviews, in this study, 
rested on the fact that this particular health-care setting is based on a team approach to 
health management. It made practical sense, therefore, to allow the nurse practitioners to 
have a collective voice about the themes that emerged from the in-depth interviews of the 
15 participants. Individual interviews with the health care practitioners would not have 
facilitated collective agreement regarding the possible recommendations that can be made 
to the Senior Management of the Cape Town City Health Department with respect to the 
existing TB treatment programme, namely DOT. 
Field Notes 
A constant monitoring process was part of the research plan and fonned an integral part 
of the data collection. This was done through keeping field notes about every component 
of the project including the study setting, the patients who utilize the health setting, the 
field visits into the community, and the logistics of carrying out the research. The 
research assistant also recorded in her study journal the verbal and non-verbal 
communication that played out during her interaction with the following: the health care 
workers at the study site, the community workers and the participants during the 
interviews. She also recorded her observations on the nature of the following: the health 
practitioner-patient interaction at the clinic, the community worker-patient interaction in 
the community setting, and the interpersonal relationships between health care 
practitioners. 
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The Principal Investigator (PI) was also intimately involved in the monitoring process 
and met regularly with the research assistant to ensure that the latter developed a high 
degree of reflexivity. Reflexivity is, according to Malterud (2001), "An attitude of 
attending systematically to the context of knowledge construction, especially to the effect 
of the researcher, at every step of the research process" (p 484). 
StaDdards for qualitative iDquiry 
Malterud (200 1) proposes that relevance, validity, and reflexivity should be used as 
overall standards for qualitative inquiry, although simultaneously warning that achieving 
standards is not simple because invariably judgements are made in the process. To 
ensure standards for the study the PI scheduled regular meetings with the research 
assistant to ensure that she understood what has to be done to achieve relevance, validity 
and reflexivity. During the meetings the PI and the research assistant (RA) reported the 
difficulties they experienced and the observations made. The RA was very receptive to 
the guidance provided by the PI. 
Relevance was enhanced in the study by using detailed reports and a good sampling 
technique and validity was improved by using procedures suggested by Mays and Pope 
(1995) such as triangulation, respondent validation, thorough methods of data collection 
and analysis, reflexivity, and attention to negative cases. 
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Etbical statement 
This project was conducted using the national and international ethical code for research 
in the social and health sciences. Ethical approval was obtained, separately, from UeT's 
and Cape Town City Health Departments ethics committees' for phases one and two. The 
study is also registered with the University of the Western Cape's Re~arch and 
Development Committee, who provided ethical approval for the first stage of the study, 
namely in-depth interviews with the TB patients (participants of the study). 
3.5 Analysis of the data 
Qualitative data analysis, which organizes phenomenological data, as suggested by 
Moustakis (1994), was used. The data was analyzed in two phases. In the first phase, the 
data obtained from the individual interviews conducted with the 15 participants was 
analyzed, and in the second phase, the data obtained from the focus group conducted with 
the health care staffwas analysed. A preliminary analysis of the in-depth interview data 
was conducted and when themes began to recur it meant that data saturation was reached. 
At this point the sampling process was considered to be complete. 
The first step in phenomenal analysis, according to Moustakis (1994), involves the 
horizonalizing of the data. This meant that each statement made by the participants of the 
study was treated with equal value. "Meaning units" were then listed out of the 
horizonalized statements. The meaning units were then clustered into themes and used to 
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develop textural descriptions of the experiences. Finally, from the textural descriptions, 
structural descriptions and an integration of textures and structures into the meanings of 
the phenomenon were constructed. 
In this study, two sets of structural descriptions were constructed. Firstly, structural 
descriptions were developed based on the meanings that TB patients assigned to their 
adherent behaviour of the treatment and prevention programmes. Secondly, within the 
framework ofth~ phem>Qlenologicai approach, structural descriptions were developed 
from the responses of the focus group members who reflected on the structural 
descriptions that ~~s~ qllt of the emergent themes of the 15 individual interviews 
',I: 
conducted with the ~ ~~ients that agreed to participate in this study. The outcome of 
the analyses is pre~~ fs presented in Chapter Four. 
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4.1 Introduction 
CHAPTER FOUR 
FINDINGS 
In this chapter, the core themes that emerged from the data, which captures the essence 
of what participants said and implied during the illness narrative, is presented. A 
demographic profile, period since onset ofTB infection, and the HIV status of each of 
the 15 participants are presented in Table 4.1. The infonnation was obtained from each 
participant in the pre-interview phase as discussed in section 3.4 
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Table 4.1 Demographic profile, duration of TB infective status, and the mv status of 
study sample 
P Age Sex Educational Level Gainfully Marital Duration of 
Employed Status TB iofeetive 
Status 
1 50 F Between grade 4-7 No Married 5 months 
2 45 F Between grade 8-10 No Married 3 months 
3 18 F Between grade 8-10 No Single 3 months 
4 20 M Between grade 8-10 No Single 5 months 
5 42 M Completed grade 12 Yes Widowed 1 month 
6 36 M Below grade 4 Yes Single 1 month 
7 49 M Between grade 4-7 No Divorced 2 months 
8 48 F Between grade 4-7 No Married 4 months 
9 27 M Between grade 8-10 Yes TSingle 15 months 
10 57 M Between grade 8-10 Yes Single 6 months 
11 124 F Between grade 8-10 Yes Single 4 months 
12 25 F Between grade 8-10 No Single 12 months 
13 30 M Between grade 8-16 No Single 6 months 
14 29 F Between grade 8-10 No Single 5 months 
15 27 M Between grade 4-7 Yes Single 3 months 
P = Participant; M = Male; F = female 
HIV 
Status 
negative 
n~ative 
positive 
negative 
negative 
positive 
positive 
tive 
positive 
unknown 
unknown 
pcsitive 
pcsitive 
negative 
negative 
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An analysis of the demographic data revealed the following: the mean age of the 15 
participants was 35.13 years (range 18 to 57 years); there were seven female and eight 
male participants; the mean duration of the disease was 4.3 months; seven participants 
were co-infected with the HI virus; six participants tested negative for the HI virus; and 
the HN status of two participants was unknown. Most of the participant's were single 
(l0), three were married, one was divorced, and one widowed. The educational status of 
the participants were as follows: A large proportion of the participants (8) had secondary 
schooling qualifications between grades 8 to 10, four participants had primary schooling 
qualifications between grades 2 to 4, one participant had a below grade 2 qualification, 
and only one completed grade 12 (matriculation). Finally, the majority of the 
participants, 10 out of 15 participants, were not in gainful employment. 
In order to capture as accurately as possible the voice of each participant, the quotations 
provided in English in this research report do not follow the technical rules of the 
English language, but rather try to capture the exact meaning of the interview data. The 
same principle regarding the use of the English language in presenting the quotes of the 
members of the focus group is applicable to phase two of the study. The focus group 
members, comprised of the health care providers at Kuyasa clinic, preferred that the 
group session is conducted in English despite the fact that English is their second 
language. 
The Xhosa-speaking, female, research assistant who conducted the individual interviews 
in phase one of the study also recorded significant non-verbal responses of the 
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participants, such as pauses, silences, and facial expressions depicting a range of 
emotions including helplessness, hopelessness and depression. Significant non-verbal 
responses of the members of the focus group were also recorded by the facilitator and 
co-facilitator. Significant non-verbal responses of the 15 participants and the focus 
group members are noted in the presentation of the findings. 
4.2 Findings: Phase one 
Two core themes emerged from the stories narrated by the 15 participants about their 
lived experience as an individual infected with m. The subjective or lived experience of 
illness reflected contextual, individual and disease factors that influence, directly or 
indirectly, whether they are willing and able to adhere to m treatment. The emergent 
themes are: (1) Contextual, individual and disease factors associated with the illness 
experience; and (2) Psychosocial factors promoting and hindering adherence to m 
treatment. 
The corresponding identity of the participants whose narratives highlight the theme 
being presented can be found in Table 4.1. 
Theme One: Contextual, individual and disease factors associated with the illness 
experience 
Life Conditions 
Many participants alluded to the fact that they have severe fmancial constraints. The 
challenging, often competing fmancial demands that participants face is illustrated by 
the statements made by a 45 year old married female co-infected with HIV and 
diagnosed with TB four months prior to the interview (P2): 
Recently I've been stressing a lot because of the finanCial difficulties that my 
husband and I are faced with. I don't work and my husband also doem't work. 
He lost his job in the mines in 1994. The children are now growing and they have 
more needs which at times we cannot meet. 
Rlness challenges 
The illness challenges that participants faced were associated with contextual, disease-
related and psychological factors. The challenges were essentially four-fold: Participants 
perceived that they: (1) were living in poorly resourced social environments, (2) had to 
endure disease-related sYmptoms, (3) experienced feelings of hopelessness and 
depression, and (4) lived with the stigma of being infected with TB. 
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All four components of the perception of the illness challenges are reflected in the 
following response of a 25 year old HIV positive female participant (P12) who was 
infected with 1'8 one year ago: 
The biggest challenge that I had to live with was having to bear with my aunt 
who each time when she got drunk would swear at me about my illness. This got 
to a point where I cou/dn't take it anymore and I left and went to my partner 
again. She made me feel like dirt. After I left home I didn't come back to the 
clinic for my treatment. I just gave up on myself and didn't find the need to care 
for myself or live. (Participant paused for a long while). At times when I cooked 
she would often come at home and say that she won't eat food that has been 
cooked by me. She would accuse me that I have spit on the food. She really made 
me angry. (Again participant paused for a long while). 
Feelings of helplessness and depression were associated with disease-related symptoms 
in this 45 year old female participant (P2) diagnosed with 1'8 three months prior to the 
interview: 
I was always tired, I didn't feellilre doing anything. I didn't want people around 
me and I was irritable. (pause, looking down) I couldn't even wash myself and 
my sister had to help me to get washed and this made me feel very angry because 
I felt helpless. 
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Of all the reported illness challenges reported by the participants, stigma associated 
with being infected with TB was the easiest to delineate. There were reports of: a lived 
experience of stigma, self-imposed stigma, and anticipated stigma. 
A 20 year old male participant (P4) who was diagnosed with TB five months ago talked 
about his actual experience of being stigmatized by people that he knew well following 
the disclosure of being aftlicted with TB: 
Yho! (participants head facing downwards) I was coughing a lot. This is when I 
started to realize that I need to start dressing warm when I go out. At school my 
friends kept on asking me what was wrong with me. When I told them that I have 
TB they teased me everyday. 
A co-infected 18 year old HIV positive participant (P3) diagnosed with TB three months 
ago illustrates self-imposed stigma: 
I was coughing a lot, I lost weight and I became ashamed and embarrassed to be 
together with my friends. I didn't know what were they thinking about me 
honestly. I then withdrew myselffrom them. (participant paused for a few 
minutes) Sometimes I was irritable and didn't feel like talking to anyone even at 
home. 
This 30 year old HIV positive male (p13) diagnosed with TB six months ago illustrates 
anticipated stigma: 
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I was ashamed Often when a guy has TB he is always teased by others. It's lila! 
there's something really wrong or funny with you. 
CQusal Attribution 
There were essentially two main types of causal attributions made by participants about 
the onset of their illness condition. Firstly, many participants saw that external factors 
such as the climate, which is out of their locus of control, as causing them to become 
infected with TB. A 42 year old male participant (P5) who was diagnosed with TB one 
month prior to the interview stated: 
I don't know. But what happened I became very sick coughed a lot and at night I 
would sweat. I guess it could also be due to the cold weather that we have here 
in this area because we are quite close to the beach. Well, I've never been ill 
before and ever since I've been in this area I have been becoming sick. What I've 
noticed is that there are a lot of other people in the area who also complain 
about their health and they also have TB. 
A 48 year old female participant (P8) who was co-infected with HIV and diagnosed with 
TB four months ago expressed the following: 
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I don 't know. I'm not a person of fJOQr health although I have had TB once in 
J 999. Also in my family no one has had TB before. Perhaps then it's due to cold 
weather. 
Secondly, some participants stated that they believe they became infected with TB 
because they were living in an 'infected' environment. Family infected with TB were 
living or came to live with them. According to the partic~ some family members 
were in denial and refused to attend the clinic for treatment, and some were aware that 
they were infected with TB but were not adhering to the treatment programme. 
According to an 18 year old female (P3) co-infected with HIV and diagnosed with TB 
three months prior to being interviewed: 
I got infected from my uncle whom I was staying with at my maternal 
grandmother's house at the Eastern Cape, in the homelands. My uncle WQS 
refusing to eat his treatment and I tried getting the assistants from the clinic to 
come and give him his treahMnt at home. He only ate his treahMnt for one week 
and thereafter he stopped again. So when I started getting sick and my mother 
heard about it she said thot I must rather come and stay with her here in Cape 
Town. I then hDd to organize with the clinic to give a referral letter thot states 
thot I am a TB patient so thot I could get treahMnt here. 
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A 29 year old female mv negative participant (PI4) talked about how she believed that 
she became infected with TB five months ago: 
I got infected from my father. During that time I was staying with my parents at 
the Eastern Cape. MY father had been su.fferingfrom TB and refused to eat his 
treatment properly. Even when the TB workers came to visit him at home and 
tried to encourage him to take his treatment, he refused 
Another young 24 year old female participant whose mv status was unknown (P II) 
explained in an angry tone about how she believed she became infected with TB four 
months ago: 
I think that I got TB from my cousin brother who also has TB. Every weekend 
last year he use to come and sleep over by our house. MY mother and I knew that 
he had TB but it wasn't a big deal because he said that he takes treatment. You 
know the funny thing is that although he claimed to be taking treatment he never 
seemed to be getting better. He use to cough a lot but we never thought of 
anything. In October when I started getting sick I decided to go to the doctor 
thinldng that maybe I hadjlu. I was then told to do a sputum test and the results 
came out positive for TB. After that my mother then found out from my cousin's 
mother that he has been sleeping around in other people's houses because he 
refuses to take his treatment for TB which seems to be something that he and his 
mother have beenfighting about. One weekendwhen he came to visit, my mother 
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spoke to him about what we heard and told him that if he is not prepared to taki! 
his treatment then he should not come to visit. But after that day my cousin 
never came back again. 
The third type of causal attribution made was life-style related and commonly .reported 
by the "male participants. These participants disclosed during the interview that they 
engaged in high-risk behaviours. which they believed caused them to become infected 
with TB. It is clear that they reflected, introspectively on their behaviour. A 20 year old, 
HIV negative participant (P4) who was diagnosed with TB five months ago stated: 
Aish! Sister I think I got TB from roaming around at night in cold weather and 
not wearing warm clothes. Like most o/the weekends my friends and I have a 
shebeen that we usually like to go to and (pause) things really happen there. We 
have lots 0/ fun, we drink alcohol, smoke and mix ourselves with nice girls. So 
most 0/ the time ones temperature is always on its peak. Ja! By the time we go 
home it's early in morning round about one, two and it's like freezing cold So, 
Jat I believe that's how I ended up being sicle. 
Another 49 year old participant (P7) co-infected with HIV and re-infected with TB two 
months ago disclosed the following: 
Mmm! Firstly I'm a person who use to enjoy having a good time. I use to be a 
guy who just didn't want to let any woman pass me by and smoked a lot. I 
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smoked dagga and I also drank a lot of alcohol. When the day came that I was 
told by the doctor at Groote Schuur that I have TB in 1995, I knew that it must 
have been from the smoking and drinking. But after my diagnosis I never smoked 
nor drank. again. 
Reaction to being diagnosed with TB 
The initial response of the participants to being told that they were infected with TB was 
one of being "ok" or "upset", Participants stated further that they overcame their feeling 
of ''upsef' very quickly because they realized that TB is curable, and that they know of 
one or more people who are or were infected with the disease. 
A SO year old female HIV negative participant (PI) who was diagnosed with TB five 
months ago stated: 
I was fine because the doctor had told me that TB is curable. So at least I had the 
hope that I was going to get better. I also remembered the time my daughter once 
had TB that through eating her medication she became better. 
A HIV co-infected, 27 year old male participant (P9) who was found to be infected with 
TB five months ago expressed his reaction to his TB status: 
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I was shocked sister but at least I lcnew that this was something that could be 
treated 
Participation in VCT 
Registered TB patients at Kuyasa clinic are advised by the health care providers to 
participate in VeT because of the high prevalence ofTBIHIV co-infection nationally 
and in sub-Saharan Africa. Once it is established whether the patient is co-infected, an 
effective and appropriate trea1rnent management plan, in addition to anti-TB trea1rnent, 
can be decided on. In the study there was a high degree of willingness to participate in 
VeT for the m virus as illustrated by the following responses by following three 
participants: 
Participant 14: A 29 year old female living with TB for the past five months: 
Yes. I did do the test and my results came out negative. I was then told to come 
back after three months. 
Participant 12: A 2S year old female diagnosed with TB 12 months ago: 
Yes and when I tested my results came out positive. 
53 
Participant 10: A 57 year old male living with TB for the past six months: 
Yes I did After I tested I was told to come back/or another test after three 
months. 
Theme Two: Psychosoeial factors promoting and hindering adherence to TB 
medication 
Individual factors and factors external to the individual are associated with adherence 
behaviour. It was evident that even those participants', who were adhering to the DOTS 
programme at the time of the interview, also had periods of non-adherence. Whether a 
participant took their TB medication or not at any particular point in time is largely 
influenced by the characteristics of the individual, the social and economic resources 
available to hirnlher, and the social and cultural milieu ofhislher family and community. 
Ftldors promoting adherence to TB medication 
In the study the participants adhering to the TB treatment, including those that have been 
re-infected with TB stated that it was not really difficult to follow the treatment regimen. 
Adherence to the programme rested on a few factors, such as experiencing relief of the 
symptoms of the disease, the knowledge that another known person recovered from TB 
by taking the medication and the hope that they will be cured by taking the treatment as 
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prescribed. Reasons commonly given for adhering to the TB medication are illustrated 
by the following responses: 
A 50 year old female participant (PI) who readily took the treatment five months ago at 
the onset of the infection and continues to take the drugs because of the symptom relief 
she experiences stated: 
I took my treatment frequently just like I'm doing right now. I didn't have any 
problems. Instead since I have been taking my treatment I feel a big relief even 
from the stiffness and the pain I always felt. 
A 20 year old participant (P4) who was diagnosed with TB five months ago related how 
the fact that his family member was cured from the disease made him hopeful that he 
would be cured if he adhered to the treatment programme: 
You see my older brother once had TB and he used to cough a lot when it 
started But then he got better again because he was eating treatment. So like 
when I was told that I have TB it wasn't a big deal because I mew that it can be 
cured 
The positive experience of the quality of health care received by the participants also 
influenced the adherence to the TB treatment. In the study when participants were asked 
about their perception of the quality of the health care they received, their responses 
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clustered only around one theme, namely, the attitude of the health care team at the 
clinic. Not a single participant commented on the positive or negative structural and 
other components of care, such as the waiting and/or treatment room(s) or the time spent 
waiting to receive treatment, and so on. 
A 50 year old female participant (PI) who was diagnosed with TB five months ago 
expressed her satisfaction with the attitude of the health care team as follows: 
The assistance that [ get at the clinic is very good. The nurses are understanding 
and they have done the best that they can for me. Sometimes even when you have 
another problem they are willing to listen to you and they'll make follow up. 
Another overwhelmingly positive response was from a 45 year old female participant 
(P2) diagnosed with TB three months ago: 
My experience at this clinic is good. [find the nurses being good at what they do 
and they are very helpful especially Sister X (name withheld). [ have no 
complaints honestly. This is where [have found real help. 
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Factors hindering adherence to TB medication 
Periods of non-adherence to the TB treatment programme was associated with: 
participants stopping the treatment when they felt they "better", when they had work or 
school commitments, and after discovering they were HIV positive. 
The following statement was made by a 49 year old male, HIV positive participant (P7) 
who stopped taking his treatment when he felt better: 
The first time I ate treatment when I saw myself getting better I decide to stop 
eating treatment. But from having done that I have learned a lesson because I 
fiel now that I need to take serious responsibility Ol1er my health. I definitely do 
not want to loose my life. 
The statements made by the following participants illustrate the periods of non-
adherence because of school or work commitments: 
Response of a 20 year old HIV negative male participant (P4) diagnosed with TB five 
months ago: 
Well I ditln 't have a problem with taking treatment. The only time I had a 
problem comingfor treatment was at the time I was writing exams in September 
for matric. But qfter that I came back again for my treatment. 
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Response of a 27 year old HIV positive male participant (P7) diagnosed with TB five 
months ago: 
Since I have been working I haven't been able to take my treatment regularly. 
After three months I was diagnosed with TB I found myself a job. I came to the 
clinic to report my problem and I requested to be given a weeldy treatment but 
the nurses refused. They stated that they need to be sure that I am going to take 
my treatment and that they need to see whether there is progress regarding my 
health. The nurses then suggested that I should rather inform my boss so that he 
can also assist me by reminding me to take my medication. I didn't like that idea 
because once my boss knows about my status then everyone at work will know. 
It is clear that in the case of the 27 year male participant that non-adherence to the 
treatment programme is more complex than simply because of work commitments. The 
participant also evidently feared that disclosing that he was infected with TB would 
jeopardize his job and he was in a double-bind because the health care providers refused 
to provide him with weekly treatment This reported non-cooperation by the health care 
staffwas only reported by this particular participant. 
The use of traditional healing systems was not uncommonly reported in the study. 
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A 4S year old HIV negative female participant (P2) who was diagnosed with TB three 
months prior to the interview re~ponded to the interviewer's prompt about being on anti-
TB drugs and using an alternate healing system in the following way: 
1 use them in the same amount because to me both treatments are strong and they 
can help me. The only extra thing with the water 1 get from the spiritual healer is 
that it also helps in keeping away evil spirits. 
A 4S year old HIV negative female participant (P2) diagnosed with TB three months 
ago reported on the periods during which she made use of alternate healing systems: 
1 did feel better after the treatment but then in the middle of 20001 started 
becoming sick again. Since then 1 was on and off. 1 drank some herbal 
medication from different herbalists. Then in 2003 my mother heard about a 
witchdoctor who said he'll be to help me. My family then had to give a sheep 
plus fifty rand to him. He also gave herbal medication to drinJc. It didn't really 
help but 1 continued to use it with the hope that 1 was going to get better. But 
what I've noticed since 1 have been using the medication from the clinic my 
health has improved a lot. 
Poor living conditions are known to also contribute to the spread ofTB, a disease which 
is often referred to as a disease of poverty. Participants reported that their state of 
poverty was most certainly a barrier to adhering to TB medication. A 42 year HIV 
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negative male participant (PS) diagnosed with TB one month ago reported. having 
limited financial constraints as one reason for not maximizing the benefits of treatment: 
One of the challenges that I have faced is not being able to maintain a healthy 
diet consistently. At the clinic the nurses tell us that we need to try and eat more 
vegetables and the money is not always there to buy such things. Most of the time 
I eat bread and tea or coffoe. 
The same participant stated: Well I feel that it would be wonderful if the TB patients 
especially those that have financial constraints to be provided with food parcels. Even if 
one day we could get an egg and perhaps on some days get soup. That would be very 
helpful. This statement illustrates that this particular participant was seriously financially 
challenged. 
An 18 year old HIV positive, female participant (P3) diagnosed with TB three months 
ago further illustrates the seriousness of the level of poverty experienced by the 
participants in this study. She stated (tearfully): 
It has been very hard sometimes for me to take treatment because sometimes I 
don't have something to eat. There are days that I need to go to (1 friend's house 
just to ask for something to eat so that I can be able to take my treatment. 
Sometimes I ask one of the nurses then she will give me from the packet of 
porridges from the clinic. The problem is that my mother doesn't work and 
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sometimes it can become really difficult because I have two younger siblings and 
all three of us go to school. We depend on the fish that my mother sells and 
sometimes business doesn't go so well at all. 
Field Notes: Findings 
The research assistant, who also carried out the individual interviews and co-facilitated 
the focus group, noted that the patients who utilized the Kuyasa health care facility were 
indeed disadvantaged and were grateful for the care provided by the health workers. 
Verbal communication between the patients and the health care providers took place in 
Xhosa, which appeared to facilitate the patient-health provider alliance. Although patients 
had to wait to receive their treatment, they did not seem to complain. 
Despite living in Khayelitsha, the research assistant found that she was very affected, 
during the community visits, by the level of poverty that the m patients were confronted 
with. She shared the feelings of helplessness with the clinic and the community health 
workers about the patients' disadvantaged status. She was also witness to the challenges 
that the community workers faced in trying to locate the patients that were not attending 
the clinic for their m treatment. These workers were not provided with transport to carry 
out their duties and had to, consequently, brave difficult weather conditions and work in 
unsafe areas. 
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Other significant observations, such as the non-verbal behaviour of the participants and 
the health providers during the individual interviews and the focus group respectively, 
made by the PI and the research assistant are incorporated into the body of the findings of 
phases one and two of the study. 
4.3 Findings: Phase two 
The themes that emerged from the first phase of the study were presented for discussion 
in the focus group with health care providers. While every attempt was made to 
systematically work: through each of the themes, it was not entirely possible to keep the 
focus group discussion highly structured because the health care workers offered 
opinions, personal perceptions and their understanding ofTB patients' adherent and 
non-adherent behaviour to the TB treatment programme linking various components of 
each of the themes presented. For this reason the themes that emerged from the focus 
group are broadly clustered around the member's perceptions of adherence and non-
adherence by the participants, in phase one, to the TB treatment programme. 
It is also important to note that the members of the focus group did not confme 
themselves solely to the responses of the participants in the first phase of the study. 
Instead the themes presented to them by the facilitator formed a springboard for the 
discussion of their own understanding of the adherent and non-adherent behaviour of the 
TB clinic patient population. Hence, they expressed disagreement when they felt that a 
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particular theme that emerged from patient interviews did not coincide with their own 
views about the general TB patient population at Kuyasa clinic. 
In the final analysis the following themes emerged from the data: (1) Perceptions 
regarding the pattern ofTB patients' adherence to TB medication, (2) Opinions of the 
DOTS strategy, (3) Recommendations to improve health service to patients, and (4) 
Additional observations about TB patients and the quality of the health care provided by 
Cape Town City Health department. 
Theme ODe: PereeptioDs oft'be factors liiDderiDg TB patieDts' ad'bereDee to TB 
medicadoD 
The feedback given to the focus group members regarding the adherence behaviour of 
the TB patients who participated in the study, focussed on both adherence and non-
adherence to TB medication. Group members, however, did not really engage with the 
pattern of adherence but did offer an extensive understanding of the reasons why TB 
patients often do not comply with the treatment programmes offered at the clinic. 
The health care practitioner's perceptions regarding the reasons why TB patients do not 
adhere to the treatment programme can essentially be categorized into five components 
of non-adherence: (a) Socio-economic status of the patients, (b) Individual 
characteristics of the patients, (c) Nature of the DOTS strategy, (d) mv and TB co-
infection, and (e) Stigma. 
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Component One: Socio-economic status of the patients 
There was overwhelming agreement by the focus group members that one of the main 
barriers to adherence to the TB treatment programme is the limited social and economic 
resources that TB patients endure. It was evident that the health care team felt helpless in 
the face of the patient's poverty and because it was a factor beyond their control, they 
could not address this barrier to adherence. According to the focus group members many 
patients often report that they are not able to meet their basic needs for food and 
adequate shelter. The patients also reported that there was a lack of an adequate transport 
infra-structure and that they found it difficult to get to the clinic because their places of 
abode and the clinic were not in close proximity to each other. Of course, the patients 
also found travelling long distances in poor weather conditions hindered their attendance 
at the clinic. The following statements reflect these perceptions of the health care team 
regarding the social and economic status of the patients at the clinic: 
It is true but also it's because some of them say they don't hove something to eat 
and that is why they don't take their treatment. Sometimes for some of the clients 
it'sfar for them to get to the clinic everyday and its worse in winter when it's 
raining. Sometimes we can understand as most of them are poor and if they get 
wet and must return to a house with no heater then we can't do anything. (Said 
with a sense of helplessness). 
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Component Two: Individual characteristics of the patients 
The individual characteristics that posed a barrier to adherence were the negative 
attitudes patients had regarding the recommended treatment programme to combat TB. 
Faced with unemployment and low household income, patients were dependant on 
others for survival. This dependency made them vulnerable and decreased their capacity 
for self-control and self-efficacy. 
However, in addition the health care team perceived many patients to be "ignorant" as 
illustrated by the statement made by one of the focus group members, which served as a 
basis for discussion as one of the reasons for non-compliance to TB treatment: "And 
sometimes its also ignorance and not wanting to taJce care of themselves, where you just 
get someone who decides that they won't talre their treatmenf'. They perceived patients 
not wanting to "take care of themselves" despite being give information about the nature 
ofTB and the consequences of not adhering to the treatment programme. 
The focus group members were also of the opinion that patients' were often resistant to 
taking their medication and made a conscious decision not to take their treatment The 
following statement illustrates this: you just get someone who decides that they won't 
take their treatment. 
The heath care team saw that there was a gender dimension to adherence, with a higher 
frequency of non-adherence amongst males. They related this to risk-taking health 
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behaviour, reflective of the perceived general risk·taking behaviour usually displayed by 
males. 
Finally, they reported that there is a sub·group of patients that experienced side-effects 
from the medication and may, therefore, voluntarily stop taking the treatment as a result. 
There was general agreement to the explanation offered by one of the focus group 
members in this regard: "Another factor that would also affect adherence is the 
reactions some of the people get from the medication and by that I mean being allergic. 
Because if you react to a specific medication then you don't want to use it again. " 
Component Three: Natll1'e olthe DOTS strategy 
The members of the focus group expressed many opinions regarding the DOTS strategy. 
They were. in general agreement that the length of the programme served as a barrier to 
adherence. Many patients comply with the treatment in the first two months and default 
as soon as they experience some relief from the physical symptoms of the disease. 
Consequently many patients become re·infecteci. 
A senior member of the health care team stated that there is an alarming increase in the 
rate of multiple drug resistance (MDR) because patients do not adhere to treatment 
consistently. When the focus group was given the feedback that that the re.infection rate 
among the participants was high, they confinned that this pattern was also reflective of 
the general TB patient popUlation that attended the clinic. One of the more experienced 
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members of the focus group stated: 8Now regarding the re-infection part that you 
mentioned it is true what you were saying because we have a lot of MDRs. 
because our clients take their treatment and then they stop. Our scale of MDRs is very 
high now and before it wasn't. (pause) In so much that we had one doctor at the time 
and he could manage all our cases and I'm talking about Khayelitsha alone not other 
places." 
The health care team also felt that daily visits to the clinic proved too demanding for 
patients. They compared DOT to other treatment programmes, such as the anti-retroviral 
(ARV) roll-out where patients were given a weekly dosage of medication. A member of 
the focus group stated: Also when they get their ARVs they receive a packet for the 
whole week and as time goes on they get a months supply as compared to having to 
come everyday for their TB treatment. Another comparative advantage of the ARV 
programme they expressed is that "the ones who get ARVs have a support system where 
there needs to be someone who reminds the patient to take medication, showing that they 
care." Clearly, members of the focus group that have experienced other areas of health 
service delivery outside ofTB care, recognize the importance of a social support system 
in improving adherence rates. 
Component Four. HIV and TB co-infection 
Patients who are co-infected tended to take their HIV status more seriously than they did 
their TB status. There was general consensus among the focus group members to the 
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following statement offered by one of them: "What you also find is that they talce HIY 
more seriously than TB. " Patients who were both on ARVs and DOT also took the 
treatment for their HIV positive status more seriously. This referred to patients who 
were on treatment for both the HI virus and TB, and does not refer to the participants. 
Component Five: Stigma 
There was general agreement that many TB patients experienced actual stigmatization or 
perceived stigmatization at home, in the community and at the work place. Stigma was 
experienced as especially problematic in the work place and many patients have reported 
to health care providers of stigmatization by employers. There was consensus on the 
following statement made by a senior member: "That·s true as some of our patients have 
reported incidents even at work. But what happens TB care does go to the workplaces of 
our patients to conduct talb about TB and issues around stigma so that those who are 
irfected are not victimised ., 
Theme Two: Opinion of the DOTS stl'1ltegy 
The health care practitioners' opinions about the DOTS strategy related to the reasons 
they thought the programme often failed. Many of these factors have already been 
presented under theme one, component three entitled 'Nature of the DOTS programme' . 
These include the fact that (1) the programme is too long, (2) daily visits to the clinic are 
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too demanding for patients, and (3) some patients experience side-effects from the anti-
TB drugs and as a result interrupt or stop treatment. 
The health care team provided additional valuable opinions regarding the TB treatment 
programme. They believed there was too much focus on the medication regimen and 
insufficient attention given to other socially supportive elements that could improve 
adherence by being built into the programme. These included support from significant 
family members, friends and health care workers who are specifically assigned to the 
task of monitoring and reminding the patient to take his/her medication. 
Finally, the health care team felt that the TB treatment programme did not consider in a 
substantial way contextual factors, especially with respect to the role of traditional 
healers. Our data supports the fact that many individuals straddle mainstream and 
alternate healing systems. Despite this the treatment for TB is not tailored to these 
cultural practices of the affected communities. Focus group members did not, however, 
discourage patients who wished to see a traditional healer whilst they were on the TB . 
treatment programme. Instead they emphasized the importance of continuing to take TB 
medication, especially at the beginning of treatment, even in the event that they decided 
to seek alternate methods of health care. This is illustrated in the following statement 
related to medication usage: "Ja and what we usually do is to discourage them from 
taking both medications. We often tell them thatfor thefirstfow days they must only use 
clinic medication as to see whether it works for them. " 
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Theme Three: Recommendations to improve health service to TB patients 
The main recommendation made by providers was the establishment of a support group 
for the TB patients' attending the clinic. They felt that as most of the education about the 
disease is provided on the day the patient is told that they have tested positive for TB, 
patients are often overwhelmed by this knowledge at the same time as being informed of 
their diagnosis. They are, therefore, unable to process and absorb all the information 
about the disease. An on-going educational support group may improve adherence rates 
to TB treatment. The following opinion offered by a senior member of the focus group 
received support from the other members and captures the essence of the critical need 
for an "on-going" support group for the TB patients: "J think on their first day after 
given their diagnosis that in itselfis overwhelming/or them and it's osldng a bit too 
much to expect them to be able to hold all that information on education. That's why J 
feel that there needs to be an ongoing support educational group. " 
Theme Four: Additional observations regarding TB patients and the health care 
provided by Cape Town City Health. 
A few important observations made by various members of the focus group regarding 
TB patients adherence to DOT and the health care provided by Cape Town City Health 
were discussed by the focus group participants. The observations that achieved group 
consensus are discussed. 
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One of the factors believed to contribute to poor TB cure rates is the fact that it is 
common for those individuals who are infected with the disease for the fIrst time to 
adhere to their anti-TB drug treatment for two months initially and then stop the 
treatment once they were feeling well again. These are the patients who often get re-
infected. 
A critically important issue raised by the focus group participants related to the 
ineffectiveness of support staff. Paid community support staffwere meant to monitor, 
especially those TB patients that do not attend the clinic for treatment as regularly as 
they should and motivate them to adhere to TB treatment. However, there was consensus 
that the support staff were ineffective and had a low work ethic as illustrated in the 
following statement: "Just to add something regarding the DOT programme, the 
community supporters who are suppose to monitor the TB patient's who can't come to 
the clinic and take sputums are not doing their job. And they do get paid R30 per 
patient.-
A factor felt to promote higher levels of adherence was the provision of food incentives 
to patients. The health care team reported that "in winter when there are soup kitchens 
that are done by community members then you find that the level of adherence goes up 
because then the patients go for soup and bread." As part of the health service patients 
receive porridge and powdered milk if they request for a food parcel or if the health care 
worker thinks it is warranted. 
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5.1 Introduction 
CHAPTER FIVE 
DISCUSSION 
A relativist perspective as opposed to a rationalist perspective underpins this study. A 
rationalist approach demands that knowledge development is based on observation and 
experimentation. A relativist position, according to Abraham (2004), is one in which the 
value of theories and knowledge is determined by historical and cultural factors that are 
dynamic and change over time. A relativist position, therefore, is not researcher or 
theorist-focussed as is the case in a rationalist position, but participant-focussed in that 
the historical and other contextual features of the person or group being studied forms an 
important component of academic knowledge construction. The findings of this study 
are discussed within a henneneutical phenomenological approach, which may be located 
in a relativist I;Jaradigm.. Within a hermeneutical phenomenological perspective health 
and illness are considered to be experiences that "occurs in a concrete situation 
involving me and others living within a historical, cultural and social setting" 
(Kugel mann, 2004, p 44). In this study the life circumstances and the life experiences of 
the participants were explored to understand the factors that influenced their ability to 
adhere to a TB treatment programme. The researcher endeavoured to set aside any pre-
conceptions about participant's adherence and instead, made every effort to allow the 
participant's construction of the factors that enhance or serve as barriers to be 
ascertained. The findings of the study, based on the integration of the patient's and 
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health care provider's perspectives, revealed that the factors that have an impact on the 
participant's willingness or ability to adhere to TB treatment reflects a complex array of 
economic, social, environmental, cultural and psychological components. Figure 5.1 
depicts this complexity. 
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Figure 5.1 Factors influencing adherence and non-adherence to TB medication 
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5.2 The economic, social, cultonl and psychological facton inDuencing adherence 
to TB medication 
The social, economic and political context ofTB 
A sense of helplessness prevailed among the participants and the health care providers in 
the face of the poor social and environmenta1 context of the participant. Factors that 
could contribute to improving the quality oflife of the participants appear to be out of 
reach for the participants and health practitioners. Unfortunately, the health proftle of the 
general patient population at Kuyasa clinic, in which the study was conducted, is 
consistent with the national disease burden proftle with respect to TB, and mv and 
AIDS. Six of the 15 participants were co-infected with the III virus at the time the study 
interviews were conducted. Personal communication with the senior management at the 
Kuyasa clinic confirmed that the almost 5()G1o TBIHIV co-infection rate of the study 
sample was reflective of the clinic's co-infection rate. 
Health authorities are experiencing difficulty in improving the cure rate for TB in the 
historically disadvantaged community ofKhayelitsha and are often challenged by the 
rate ofre-infection of the disease. Individuals who are committed to better health 
outcomes for themselves often face social and economic constraints that are beyond 
their control and prevent them from making health-enhancing choices. They are 
confronted with unemployment because they lack skills consistent with current labour 
demands and have low levels of formal education. 
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The fact that TB is considered to be a disease of poverty is clearly reflected in this study. 
All the participants endured the experience of being poor and had a lived experience of 
the consequences of poverty, namely crowded and often dangerous living conditions, 
unemployment, limited formal education, limited social support and a narrowly dermed 
social network, poor infra-structure, and general ill-health in their families and the 
community. The brutal level of poverty that participants in this study faced often meant 
that they were living below the breadline and unable to meet theirs' and their fiunilies' 
basic need for food, clothing and decent housing. The health care practitioners and the 
research assistant that carried out the individual interviews in the study also experienced, 
through the voice of the participants, the extent of poverty that patients are confronted 
with. The research assistant was also "witness" to the poverty when she accompanied 
the community health workers to locate TB patients who were non-adherent to the TB 
treatment programme. This is confirmed by the findings of the South African burden of 
disease study conducted by the Medical Research Council, which indicates that 
mortality due to diarrhoeal disease, TB and nutritional deficiencies, is significantly 
greater in the poorer provinces and rural regions (Bradshaw, Nannan, Laubscher, 
Groenewald, Joubert, NojiIana, Norman, Pieterse, & Schneider, 2004). Political will 
towards the progressive realization of rights for all South African citizens is critical 
within a health care context because good physical and emotional well-being clearly 
rests on an acceptable standard of living. Historically, individuals higher on a social 
stratum have enjoyed better health than those below (Farmer, 1999). 
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Participant's feeling of impotence within the context of such poor living conditions is 
illustrated by the fact that they have the infonnation that anti-TB drug treatment is more 
effective if an individual is well-nourished but had to often conftont the fact they 
sometimes could not afford to buy basic food items, let alone the ''nourishing'' food 
recommended by the health care workers. Thus the vicious cycle of poverty and iII-
health continues. 
It was evident during the research process that individuals bom into sprawling, over-
crowded and poor townships, such as Khayelitsha, during the apartheid years continue to 
face hardships. The cycle of poverty persists in South Africa despite the changing face 
of politics to one of democratic governance. 
Causal Attribution 
Ascertaining the causal attributions made by the participants about how they became 
infected with TB provided a deeper understanding of their adherence to treatment for 
TB. Attribution theory, according to Kelly and Michela (1980), is ''the study of 
perceived causation .......... , the term attribution referring to the perception or inference 
of cause" (p. 458). Attribution, which is essentially a cognitive process, involves 
systematic assessment and/or manipulation of the infonnation an individual gathers and 
hislher beliefs. Causal explanations are centrally linked to the attributional process. 
Attribution theory is widely used within a health psychology context in order to 
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understand some of the factors that contribute to health enhancing behaviour(s) and 
hindering health behaviours of individuals. 
Kleinman and Kleinman (1991), within an ethnographic paradigm, state that social, 
cultural, and,political factors act as a mediator to an individual's illness experience and 
will contribute to the way in which an individual constructs explanations for hislher 
illness. The causal attributions that individuals assign to their illness condition will affect 
their way of coping with it. If a treatment regimen recommended by a health practitioner 
is consistent with an individual's understanding of what caused his or her illness, then 
the individual is more likely to adhere. An individual who ascribes external factors that 
are out ofhislher control as causing the illness, is less likely to be self-motivated to 
improve hisJher health status as compared to an individual who rates highly on self-
efficacy. Those high in self-efficacy believe that they are able to carry out tasks and 
engage in behaviours that matter and provide direction in their lives. Increased levels of 
self-efficacy has also been associated with better disease management, such as adhering 
to prescribed medicines, managing stress and following a recommended nutrition 
programme (Clark & Dodge, 1999). The reality is, however, that in socially and 
economically under-resourced communities there may well be factors that individuals 
have very little control over. This presents as an immense challenge for many 
individuals in these communities who rate high on self-efficacy and have the personal 
will to improve their quality of life but are overwhelmed by their currently adverse life 
conditions and are unable to effect changes in the short-to-medium term. 
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In this study the complex interrelationships between environmental, social, cultural, and 
personality factors are evident in the way participants' constructed causal explanations 
for m. The inability to control the factors that contributed to the cause of the onset of 
m was one of the dominant themes that emerged from the individual interviews with 
the participants in phase one of the study. Cold and damp weather conditions as a causal 
explanation for the onset ofm was common among the participants (e.g. P5, P8). 
Assigning climatic and poor living conditions as causes for the disease possibly render 
people helpless in the face of ill-health because they do not have control over both these 
factors. Health practitioners' concurred with this because they were also reduced to a 
state of psychological helplessness in the face of the patient's extreme level of poverty. 
Certain social and cultural influences, which were beyond the participants' control, were 
also considered to have caused the onset ofm. In particular, participants (e.g.PI4, PI 1) 
alluded to the fact that they lived within a patriarchal family system with men having 
relatively more power around decision-making. The participants perceived that, the fact 
that male members of the family did not want to present themselves for treatment fuelled 
their m infection rate. It was evident that participants who believed that they were 
infected by close family members felt betrayed by their irresponsible behaviour and their 
lack of due consideration for others. Ultimately, participants felt devalued in the family 
home. Women in patriarchal families perhaps do not feel sufficiently empowered to 
assert their rights, needs or desires and, in fact may not be permitted to articulate their 
opinions (Doyal, 1995). These findings alert us to the fact that health in South Africa 
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should be looked at critically and the health experience of individuals should also be 
located within the discourse of gender, class and ethnicity/race (Naidoo, 2004). 
The fact that participants believed that they were infected with TB by significant others, 
mostly family members, who were indeed non-adherent to treatment, provides good 
insight into one of the possible mechanisms in recurring infections within families and 
communities. The challenge that health authorities face, with respect to improving the 
cure rate for TB, therefore, is that many infected individuals do not present themselves 
for treatment despite knowing their diagnosis and the consequences offailing to take 
treatment. One may also surmise that these individuals do not believe that adhering to 
the recommended treatment of the local health authorities will cure their illness 
condition and possibly view the treatment methods with skepticism and mistrust. Of 
course the individual characteristic of having an "optimistic bias" within a health context 
may also explain why these individuals refuse to take treatment. ''Optimistic bias" refers 
to "the belief that other people but not one's selfwill develop a disease, have an 
accident, or experience other negative events" (Brannon & Feist, 2000, p 106). 
Perhaps another reason for the resistance towards health promoting behaviour on the 
part of the male members of the families concerned is reflective of a fear of disclosure of 
their infected status and the associated stigma. If they are labelled as an individual who 
is aftlicted with a disease condition, their power within the family decreases. The fear of 
being co-in1ected with mv is yet another reason that some individuals may not present 
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themselves for treatment. This is based on the assumption that they have the information 
that there is a high TBIHIV co-infection rate in the community. 
A subgroup of both younger (e.g. P4) and older male participants (e.g. P7) in this study 
were fairly introspective in that they made the causative link between their high-risk life-
style and the onset ofTB. The disclosure on the part of the older males, in particular, 
helps to challenge the commonly held expectation that it is predominantly the youth and 
young adults that engage in risky behaviour that is detrimental to their physical and 
mental well-being. 
TB infection: a norm in the community? 
It was evident in the study that the participants did not appear to experience 
psychological distress to any great extent after knowing that they tested positive for TB 
(e.g. PI). Their response to being diagnosed with TB was, however, significantly 
different to being told they were HIV positive. This is true for those participants that 
agreed to take the HN test following veT at Kuyasa clinic. The participants who tested 
HN positive reacted with "shock" (Ross & Deverell, 2004) and dismay and in many 
instances stopped adhering to the TB medication. 
Perhaps the participants did not react with • shock' when they were informed by the 
health care provider that they had TB because of the fact that they were aware of the 
high prevalence of TB in the community. Further, their knowledge that TB is curable 
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possib1y 1ed them to take this disease status less serious1y than they would HIV and 
AIDS. This opinion is also shared by the health care workers who stated that m patients 
who are co-infected with HIV tend to take their HIV status more seriously than their TB 
status. This may imply that patients' do not fully comprehend the relationship between 
TB and HIV, and the importance of adhering to the m treatment regimen when having 
a compromised immune system due to mv. Perhaps a clearer message needs to be 
conveyed to these patients, through a health education process, that in order to contain 
the spread of these co-infectious diseases, such as m, and maintain an optimum level of 
physical health, those who are HIV infected have to adhere to TB treatment. A culture of 
optimism needs to be created by the health care team to encourage the affected 
individuals to see that the overall improvement in their quality of life rests on being 
disease free (in the case of an infectious disease, such as TB). 
The apparent normalization of their TB infected status may also reflect the participant's 
attempt at achieving equilibrium in their lives by maintaining their self-identity. This 
psychological process allows individuals to maintain an internal balance and appear 
"normal" to others. The process of normalization also allows the individual to be just 
like the "other" because being different places them in a marginalized position. This 
may be especially true in stigmatizing illness conditions, such as TB which is infectious 
and can be transmitted from one individual to anther (Friedman, 2002). 
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Rlness challenges 
The illness challenges that participants in this study faced, clustered around social and 
economic, disease-related and psychological factors. The economic factors and the 
social factors have been discussed, to some extent, earlier in the chapter. However, due 
to the complexity of the participants' illness experience and the interrelationships 
between the social, economic, cultural, disease-related and psychological factors, these 
factors as they relate to the challenges of having TB merit further examination. 
Social Support 
The social and familial environments of the participants were not unquestionably 
supportive (e.g. P 12). In fact, family support, or lack thereof, appears to be gendered. 
Women in the families of those infected with TB played a more supportive role. This is 
consistent with research, which indicates that women tend to fulfil nurturing roles and 
are more emotionally "giving" because it is what society in general and certain cultures, 
in particular, expect of them (Mark et al, 2000). Males in the families of the participants 
were seen to be contributing to the spread of TB because they did not adhere to 
recommended treatment programmes for the disease and were, consequently, perceived 
as unsupportive. Moreover, there was an implication that the patriarchal nature of these 
families allowed the men to make unilateral decisions even if these decisions did not 
serve the interest of other family members. The men did not appear to consciously 
consider the consequences of their non-compliant behaviour with respect to the risk and 
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dangers of infecting others. This lack of • critical consciousness' conttibutes to the 
perpetuation of the vicious cycle of disempowerment, particularly of women, in certain 
communities (Campbell, 2004). 
Emotions associated with the illness experience 
A sense of hopelessness and depression, with underlying anger. prevailed among the 
participants in this study (e.g. P2, P12). This is especially true during the initial phase of 
the disease. At the time the diagnosis oflB is made, many patients are in the acute 
phase of the disease and are therefore symptomatic. Symptoms experienced during this 
period often render patients functionally impaired and dependant on others in order to 
manage their activities of daily living (e.g. P2). Essentially, patients feel they have 
limited control of their lives and may develop a sense of helplessness. According to 
Seligman (1975) people who are in an adverse situation, which they feel they cannot 
control may develop learned helplessness. Most participants reported that they found 
being in a perpetual state of exhaustion and incapacity for self-care, especially with 
respect to their personal hygiene, very challenging. Often this resulted in self-imposed 
isolation and feelings of loneliness. Studies have shown that an individual with a serious 
illness, who loses their independence and is forced to endure limited mobility because of 
the nature of the illness, becomes depressed (Koening & George, 1998; Williamson, 
1998, Newman & Mulligan, 20(0). 
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The associated feelings of anger experienced by participants was directed towards close 
family members who were perceived to have TB and were not on treatment, or have had 
TB and did not take treatment at the time they were infected. Participants believe that 
they have been infected by irresponsible adult family members who were in denial of 
their own diminished health status. 
Stigma 
Participants perceiVed being stigmatized as another m~or challenge of being infected 
with TB. It was evident that many participants withdrew from the members of their close 
social network because they felt "ashamed" and "embarrassed". In this instance the 
stigma was self-imposed. Participants (e.g. P4, Pl2) reported being directly stigmatized 
within their families and in the community. This actual experience of facing prejudice, 
discrimination and disadvantage is termed "enacted stigma" by Kelly (porter, 1999). By 
and large most of the participants anticipated that they would be stigmatized if they 
disclosed their TB infected status. This fear of anticipated discrimination is referred to as 
"felt stigma" by Kelly (porter, 1999). In this study "felt stigma" is likely to be 
complicated because of the SOO;O HIV co-infection rate of the sample, as HIV remains a 
highly stigmatized illness in many South African communities (Ross & Deverell, 2004). 
Participants who were co-infected with the In virus perhaps experienced increased 
levels of anxiety and avoided disclosing their health status for fear of both enacted and 
felt stigmas. Disclosure of their TB infected status and HIV positive status could 
possibly lead to double stigma. Goffinan (1963) suggested that when individuals try to 
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preselVe their identities they present themselves to others in a certain way, which may 
not be consistent with the "true self'. Participants in this study, therefore, may have 
increaSed levels of anxiety and depression because they are not able to freely express 
their individual identity, which is partly constituted by their state of health. 
Patterns of adherence 
The complexity between adherence and non-adherence behaviour to the same treatment 
programme by the same individual poses a huge challenge to health practitioners who 
are striving to improve the cure rates for TB. The findings in the study revealed that 
neither adherence nor non-adherence were absolute. There were clearly periods in which 
the participants adhered to the TB treatment and there were periods in which they were 
non-adherent. 
Factors favouring adherence: symptom relief, effectiveness of drugs, and total recovery 
fromTB 
Adherence to the treatment programme appeared to be better during the initial, acute 
phase of the illness when the participants were more symptomatic. They experienced 
symptom relief by complying with the recommended drug therapy for TB (e.g. PI). 
Those participants who continued to adhere to the treatment programme for TB were 
hopeful that they will recover fully because they were aware of the effectiveness of the 
drug. Many participants reported that the TB medication cured members of their family 
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and friends who were infected with the disease (e.g. P4). This finding is consistent with 
other research, which suggests that compliance to medication is positively associated 
with the patient's beliefs about the benefits of taking the drug (Marks et ai, 2000). This 
study also lends support to the Health Belief Model (Becker & Rosenstock, 1984) in that 
the participants that adhered consistently to the TB medication believed in the 
effectiveness of the drug and its ability to cure them. 
Factors favouring non-adherence 
(1) Symptom reliefrFeeling better" 
The reasons for the periods of non-adherence reported by the participants were many. 
Participants reported that they stopped attending the clinic for treatment as soon as their 
symptoms improved and they were "feeling better" (e.g. P7). This pattern of non-
adherence has been found in other conditions as well. Patients who are taking 
medication to lower their cholesterol level, for example, may stop taking their 
medication because they have no symptoms. According to Jaret (200 1), becoming 
symptomless may lead to the inconvenience of taking the drugs on a daily basis 
outweighing the benefit of remaining on the drug. 
87 
(2) First time infections 
A fair number of participants, in this study, who were re-infected with TB, admitted that 
they had been non-adherent the first time they were diagnosed. At the point of re-
infection they made a more concerted effort to take the prescribed treatment, possibly 
because they fmally acknowledged and accepted the extent of their vulnerability to ill 
health. Perceived susceptibility to the negative consequences of non-compliance and the 
perceived severity of these consequences play an important role in influencing 
compliance to health-related behaviours as suggested by the Health Belief Model 
(Becker & Rosenstock, 1984). Patients who do not cooperate during the first episode of 
being infected with TB may underestimate the seriousness of a communicable disease, 
such as TB, and the reasons for having a regimented treatment programme. Fogarty 
(1997) uses the theory of psychological reactance to explain this form of non-
cooperation. The more extensive and complex the treatment is, he argues, the more 
likely patients will perceive the treatment repertoire as a threat to their personal freedom. 
In this context, non-adherence may be viewed as a means of resisting medical 
dominance (Fogarty, 1997; Trostle, 1988). 
(3) Side-effects 
The health practitioners' at the Kuyasa TB clinic stated that the side-effects of the anti-
TB drugs should not be under-estimated. Many TB patients attending the clinic stopped 
taking their medication because they experienced severe side-effects. IU-health caused 
88 
by a health care practitioner, sometimes by virtue of the pharmacological drugs he/she 
prescribes, is called iatrogenic illness (Friedman, 2002). Non-adherence because the 
patient is unable to tolerate the drug therapy may, therefore, be beneficial to the patient 
at times. In America, it is estimated that 100 000 deaths occur as a result of medical 
errors, which range from poorly performed surgery to unsuitable drug therapy (Kobn, 
Corrigan, & Donaldson, 2000). However, despite the information provided by the health 
care providers, none of the participants in the study enlisted medication side-effects as 
one of the reasons for not cooperating with DOT. 
(4) Disclosure, stigma and associated job loss 
Another reason for non-adherence among the participants in gainful employment was 
their commitment to their work and their fear of losing their jobs if they disclosed their 
health status (e.g. P 15). Perhaps for these individuals the knowledge of the devastating 
consequences of not treating an infectious disease, such as TB, poses a double-edged 
sword. On the one hand, work is what defines their individuality, provides purpose in 
their lives, helps shape their identity as a productive member of their family and 
provides their material means to support. Therefore, to lose their job would reduce them 
to the extreme poverty experienced by the majority of people in the impoverished 
township ofKhayelitsha. On the other hand, knowing that non-adherence to the 
recommended treatment regimen for TB not only endangers their own health but the 
health of the members of their close social network, and may also lead to losing the 
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dignified existence that being in employment offers. Hence they find adherence being 
influenced by conflicting factors. 
In the case of the employed participants, disclosure oftheirTB status may also lead to 
stigmatization, victimization and marginalization because the disease is viewed by 
others as a "contagious" disease, thereby implying that the infected person is 
"contaminated". In a study conducted in Vietnam it was found that the reluctance of 
individuals to seek treatment for TB was associated with fear of stigmatization and the 
(mis )perception that TB is a "dirty" and incurable disease (Johansson, Diwan, Huong & 
Ahlberg, 1996). Moreover, the participants in this study who were co-infected with HN 
were perhaps fearful of "double" stigmatization if their health status was discovered. 
Fear of disclosure of ill-health and associated stigma has been found among individuals 
afflicted with various conditions. People with mv, for example, were reluctant to 
disclose their illness and often did not take their medication in public because others will 
become aware of their illness (Johnstone Roberts & Mann, 2000; Segal~ Schrimshaw & 
Raveis, 2000). Similarly, Smith, Francis and Rowley (2000) found that individuals with 
mental health problems reported feeling stigmatized because of their drug treatment 
regimen. In South Africa there is an increasing awareness ofTB and mv co-infection in 
the workplace because of the pressure placed on private and public institutions, by the 
government, to progressively realize the health rights of workers. 
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(5) Use of an indigenous/alternate healing system 
The use of an African indigenous healing system was also associated with periods of 
non-adherence to the TB treatment programme among the participants in this study (e.g. 
P2). Consulting with a traditional healer during times of ill-health is deeply embedded in 
the psyche of African people and forms part of the African cultural identity. Bengu 
(1989) found that one of the reasons that black psychiatric patients did not adhere to 
mainstream treatment is that they opted to consult traditional healers because they 
received individualised care. In addition traditional healers were perceived to provide 
psychological support to the patients and their families without labelling or stigmatizing 
them. Many studies (e.g. Roberson, 1992; Lumme-Sandt, Hervonen, & Jylha, 2000) 
have found that alternative or "non-pharmacological" treatments are widely used by 
individuals diagnosed with illness conditions, such as asthma and hypertension. In 
developed countries it is estimated that about half the general population uses 
complimentary and alternative medicine (Ernst, 2003). In this study, participants 
generally stopped adhering to TB treatment after the initial contact with the traditional 
healer. They soon learned, however, that the indigenous system of healing and the 
treatment programmes suggested by health care practitioners', who served as agents for 
the mainstream health system, could be used in a complimentary fashion, and may have, 
therefore, used both simultaneously. 
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(6) TBIHN co-infection 
Non-adherence to TB treatment also occurred after participants discovered that they 
were co-infected with the HI virus. The emotional reaction to the news of their HIV 
positive status was probably one of shock, psychological numbness and disbelief (Ross 
& Deverell, 2004). This feeling of being overwhelmed with this news hampered the 
participants from psychologically integrating and accepting their TB infected and HIV 
positive status. Instead they needed time to process the fact that they were also afflicted 
with HIV, an incurable disease. 
(7) Lack of family support 
Family instability and unsupportive family members were associated with the disruption 
of treatment. There is evidence to show that when individuals suffering ill-health are 
faced with disharmony in their families, experience family instability or social isolation, 
they are less likely to comply with medical treatment (Baekeland & Lundwall, 1975; 
Porter, 1969). 
Quality of health care 
Participant's equated "nursing" care with the quality of health care received. They were 
very positive about the attitude of the health care practitioners (e.g. PI, P2). All the 
participants, except one, expressed their appreciation that the TB clinic staff often went 
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beyond their call of duty by listening to them about the difficulties they were 
experiencing in their personal lives. The relationship that the health care practitioner's 
and the participants shared is indicative of a good ''therapeutic alliance", a process in 
which the practitioner effectively communicates the patient's problem and formulates a 
management plan that is conducive to patient compliance (Brock & Salinsky, 1993). 
This demonstrates a patient-centred approach to health management because the 
biological, psychological, social and cultural aspects of a patients' life are considered. A 
good therapeutic alliance is underpinned by trust, empathy and positive regard (Rogers, 
1961). Additionally, the participants who were gainfully employed at the time the 
interviews were conducted stated that the ''nurses'' were often "sympathetic" and 
provided the prescribed drugs for the days they were unable to attend the clinic because 
of work-related reasons. There is evidence that good communication between the health 
practitioner and patient is the most powerful predictor of adherence or more 
appropriately, concordance. Weiss and Britten (2003) state: "Crucially, concordance 
advocates a sharing of power in the professional-patient interaction" (p 493). 
The willingness of participants to agree to be part of the VCT programme for the In 
virus was encouraging because this meant that they were keen to know their mv status. 
This may imply that the clinic health care staffreadily gained the trust of the participants 
by imparting knowledge ofTB, mv and AIDS as transparently and honestly as possible 
in order to influence the patient's decision to take the mv test. Willingness to be tested 
for the HI virus at Kuyasa clinic is a reflection of both the quality of heath care received 
and the personal motivation of the individual taking the test to know their HIV status. 
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The patient-practitioner alliance is critical to good health outcomes because it fosters a 
mutually agreeable health management plan for the patient. 
The health care practitioner's provided their perspective on some of the reasons they felt 
the quality of health care provided, in the context ofTB, has not reached an optimum 
level. In particular, they believed that community support staffwere not fully committed 
to the TB prevention drive despite receiving remuneration for the work they do. The 
support staff were meant to specifically target those individuals not adhering to the TB 
treatment programme and motivate them to attend the clinic for the treatment and 
prevention programmes. Perhaps the support staff in the community face challenges that 
they are unable to meet and, therefore, appear ineffective in carrying out their 
responsibilities. The research assistant in this study gained insight into some of the 
reasons why community workers were not motivated. These reasons include the fact that 
it is often difficult to trace patients who are not adhering to the TB treatment programme 
because they do not live in the same abode long enough, have died or are simply 
resistant and avoidant. Working conditions are also hazardous for community health 
workers because they carry out their duties "on foot" even in adverse winter weather 
conditions and of course their personal safety is often threatened in certain high crime 
areas ofKhayelitsha. In a similar community-based model using volunteer health 
workers to improve adherence of notified TB patients to anti-TB treatment in an under-
resourced area called Elsies River in the Western Cape, Dick, Schoeman, Mohammed 
and Lombard (1996) found that the supervision and support of the volunteer workers did 
not significantly increase cooperation in adult patients. Both paid and volunteer 
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community health workers perhaps have difficulty in influencing the health-seeking and 
health-enhancing behaviours of the adults in the affected communities. 
Limitations of the study 
The results of the study cannot be generalized to the TB patient population at Kuyasa 
primary health care clinic because of the small sample size. An understanding of the 
factors that enhance adherence and the factors that serve as barriers to adherence to TB 
treatment may only be applied to the 15 participants in the study. Perspectives on 
adherence provided by the health care practitioners is only applicable to the setting in 
which the study was carried out. While the ''richness'' of the data collected in a 
qualitative study is undoubted, the data does not always reflect the phenomenological 
dynamics of the individuals participating. Individual in-depth interviews, which captured 
the participants' ''voice'' and subjective experience, may not be an entirely accurate 
reflection of what they feel, think and do within a self-regulatory health-enhancing 
context. Participants may articulate mostly what they think the interviewer wants to hear 
and may not disclose some of their or the health providers, what they perceive to be, 
socially undesirable qualities. Similarly, the health care practitioner's may not have 
disclosed un-reservedly about what they perceive to be the flaws in the health care 
system that may serve as barriers to adherence because an important stake-holder in the 
process was their senior management. 
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Significance and recommendations 
Significance 
The Principal Investigator (PI) did not impose a research agenda on the Cape Town City 
Health Department (CTCHD). Instead she collaborated with the Director and his 
management colleagues to ascertain their need with a view to improving the public 
health care service they provide. In this study the complex array of social, economic, 
cultural and psychological factors that influence whether an individual adheres to the TB 
treatment programme, is explored from the patient's and the health care practitioner's 
perspectives. This approach to the study of adherence to medical care deconstructs the 
prevailing literature, which commonly conceptualizes adherence from the medical 
profession's worldview (Trostle, 1988). The integration of results from the patient's and 
the health care practitioner's perspectives allowed, albeit, in a limited way to gain a 
deeper knowledge of the nature of the TB patient population at the clinic. The approach 
adopted by the researcher in interfacing psychology and public health is consistent with 
the current demand for more in-depth knowledge of the behavioural correlates of health 
and health behaviour so that individual health outcomes may improve. Wilkinson and 
Marmot (2003), in a World Health Organization publication, highlight the importance of 
having a thorough understanding of the social determinants of health. 
The richness of the data captured in this study and the subsequent interpretation of the 
findings was enhanced by the fact that the interviewer was Xhosa-speaking and 
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understood, without prejudice, the challenges that the participants faced because she 
lives in the same township. This meant that there was a relatively equal power relation 
between the interviewer and the participants. The fact that the interviewer was equipped 
with the qualifications of a clinical psychologist meant that she was able to skilfully 
guide the interviewer-participant alliance. 
Recommendations 
It is recommended that: 
(1) there is greater commitment by the public health sector, in particular the (CTCHD), 
to patient-centred and community-centred health promotion strategies (Campbell, 2004). 
(2) support groups are run at the clinic for TB patients, especially those infected for the 
ftrst time. TB patients who are co-infected with HIV would also benefit from a support 
group process, which may focus on the broader illness experience and the 'triple-stigma' 
experienced by co-infected patients. The concept of 'triple stigma' arises out of the fact 
that TB is a contagious disease, and HIV is both sexually-transmitted and is terminal. 
(3) a more comprehensive TB treatment programme should be adopted in the 
Khayelitsha community. The TB treatment package should include: food parcels, social 
work services to facilitate family stability and family involvement, a dedicated staff 
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member to liaise with employers, and mental health professionals to assist patients who 
are depressed, marginalized and stigmatized. 
(4) the merits of "importing" the components of other models of treatment and health-
promotion, such as the HIV and AIDS health management model, into anti-TB care, 
should be explored. Getting a family member, friend or community member to playa 
supportive role during the treatment period is widely used, for example, in the ARV roll-
out. Developing community resources and increasing social capital are effective avenues 
towards maintaining the health and well-being of a society (Campbell, 2004). 
(5) there should be greater efforts for collaboration with religious and traditional healing 
institutions to highlight the health care needs of the Khayelitsha community and to 
explore the potential for a 'combined mainstream, traditional and religious health care 
. system'. It is evident from the study that many patients straddle traditional healing 
systems and mainstream health care. 
5.3 Conclusion 
Adherence to TB treatment in the Public Health sector must be understood within the 
context of the individual characteristics of the TB patient, their social, cultural and 
economic situation and resources, and the health care setting. While some factors that 
influence adherence to the treatment for TB may be under the personal control of the 
afflicted individuals, many patients appear to experience barriers to adherence that are 
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out of their personal locus of control. Participants were, in general, knowledgeable about 
the disease, its infectious nature, and the effectiveness of drug therapy but nevertheless 
acknowledged that they had periods of non-adherence. Non-adherent behaviour in this 
public health context is complex. Factors that appear to be strongly associated with 
periods of non-adherence include poverty, HIV co-infection, stigma and unsupportive 
social and work: environments. 
Factors that underpin the association between non-adherent behaviour and a fear of 
being stigmatized are complex. While on the one hand in the Khayelitsha area the 
prevalence of TB is high and becoming infected appears to be somewhat "normalized" 
in this community. On the other, despite this participants still report actual or perceived 
stigmatization. Stigmatization in the work place may occur as employers are focused on 
maximum productivity, which is dependant on a "healthyot work-force and may, 
therefore, not take kindly to employees being ill. This apparently contradictory situation 
that in which community stigmatisation of individuals with TB within a high prevalence 
setting such as this one occurs, needs further exploration. 
The prevalence of helplessness, hopelessness and depression among the participants of 
this study is possibly one of the most significant psychological contributors of non-
adherence to TB treatment. Having an infectious disease such as TB is burdensome and 
to be part of a treatment programme for at least six months is taxing. Moreover, these 
individuals have social and economic constraints. This combination of factors may lead 
to a sense of helplessness and hopelessness because those afflicted with TB may 
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genuinely not have any control over their circumstances, which consequently reduces 
their ability to improving their health status by adhering to the treatment programme. 
An integration of the participants and the health care provider's perspectives indicate 
that adherence to TB treatment in a public health service must be understood within the 
context of poverty, the health belief system of the individual, cultural beliefs and 
practices, social support, stigma, the high rate of TB and HN co-infection, the health 
practitioner-patient alliance, and the nature of the DOTS strategy. Non-adherence to TB 
treatment clearly poses a challenge to the already over-burdened public health system in 
South Africa. 
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Appendix One 
• 
UNIVERSITY OF CAPE TOWN 
DEP ARThffiNf OF PUBLIC HEALTH 
INFORMED CONSENf FORM 
Dear Participant 
You have already been informed by the nurse in charge of the TB clinic that I am 
carrying out a study which looks at why some patients with TB are able to follow the 
treatment programme given to them by health care workers (including doctors and 
nurses), and some 1B patients are not able to. Thank you for allowing the person who is 
helping me to carry out the study talk a little more about the details of the study and also 
answer any questions you may have about the study. If you decide to participate then the 
responses you give us, combined with what other TB patients tell us, will help health care 
workers gain a better mderstanding of your experiences as a 1B patient The results of 
the study win, therefore, assist health care workers to develop a better way of treating 
TB, which is more suitable to the needs of the patient 
If you decide to take part in this study, you will be involved in two ways. Firstly, you will 
be requested to complete a questionnaire which asks you about yourself. Other 
information that we need, such as the details of your treatment, win be obtained from 
your file at the clinic. Secondly, you will be interviewed fur aboot an hour and a half to 
two hours. A specially trained research assistant will interview you in the language of 
your choice. I will supervise each and every step of the study. You have a chance to ask 
questions about the research project at any point before, during, and after the interview. 
To make certain that what you say during the interview is properly recorded; the 
interview will be taped and these tapes will only be used for the purpose of this study. I 
would also like to ask you to allow us to do this. 
Please be assured that your participation is entirely your choice and that any information 
gathered from you. and other TB patients. during your involvement in the study will be 
kept in the strictest confidence. Your real name will not be used in any public document 
including written reports. Your real name will also not be used in any public talks that 
may be given based on the results of the study. Instead, you and any other person and 
places names involved in your case will be changed so that no one will know who you 
are. 
You also have the right to withdmw from the study at any point and if you decide that 
you do not want to continue taking part in the study, you may do so and you will continue 
to receive the same treatment at the clinic. 
Permission to conduct this study was obtained from the University of Cape Town, 
through the Department of Public Health. Permission was also gnmted by the relevant 
authorities of Cape Town City Health. The University of Cape Town, Cape Town City 
Health, and the two funders for the proj~ the University of the Western Cape (UWC) 
and the National Research Foundation (NRF). They are also aware that the results of this 
study will be published. Feedback will be given to the Cape Town City Health 
management and staff, and suggestions will be made about how to strengthen the existing 
TB treatment and prevention programme. The clinic staff is also fully informed about this 
study and will treat the TB patient's in the same way whether or not they are involved in 
the study. 
Finally, please feel free to ask questions at any time during the interview. You may also 
call me, Pamela Naidoo, on the number(s) indicated below if you would like to discuss 
anything to do with the study. Once again, thank you for considering being part of this 
study. Kindly sign the Informed Consent Agreement Form if your final decision is to take 
part in the study. 
Sincerely 
ASSOCIATE PROFESSOR PAMELA NAIDOO 
PRINCIPAL INVESTIGATOR 
Cell: 083 776 11 44 
Office: 959 283519595 2283 
INFORMED CONSENT AGREEMENT FORM 
I, --------------------------------, understand the reason why the study is being 
conducted and exactly how the study will be done. My participation is entirely my own 
choice. Further. I am fullyawap'e that I have a right to refuse to continue to take part in 
the study at any point during the study period. 
PARTIPANTS SIGNATIJRE DATE 
SIGNATURE OF RESEARCH ASSISTANT: DATE 
IYUNIVESITI YASE NTSHONA KOLON! 
IFOMU YEMVUMELWANO EY AZISIWEYO 
Mthatbi-nxaxheba Obekekileyo 
Enkosi ngokuvuma ukuthatha inxaxheba koluphando, olunjongo yokuhlola izizathu 
ezibangela okokuba izigulana ezinesifo sephepha (TB) ziyilandele inkqubo yonyango 
enikwa zona ngonompilo, ukuquka (oogqirha kunye nabongikazi), zize ezinye 
izigulana ezinesifo sephepha zingayilandeli. 
Inxaxheba oyakuthi uyithathe iyakutbi incede onompilo ukufumana ulwazi olungcono 
ngamava olruba ngumntu ofunyaniswe enesifo esosulelayo. Iziphumo zoluphando 
ziyakwazisa indlela yokuphuhlisa unyango lwesifo sephepha, eyakutbi ihambelane 
ncakasana neemfuno zezigulana. 
Kukho amabakala amabini ayimfuneko kwinxaxheba oyakuyithabatha koluphando. 
Okokuqala, uyacelwa ukuba uphendule ngokupheleleyo uluhlu lwemibuzo eyakuthi 
ibuzwe ngawe kwaye kunye naluphina ulwazi olungezelelekileyo oluyakutbi lufuneke 
luyakuthatyathwa kwifayile yakho yaseIdiniki. Okwesibini, uyakuthi uthatyathwe 
udliwano-ndlebe oluyakuthabatha iyure enesiqingatha ukuya kwi yure ezimbini. 
Oludliwano-ndlebe luyakwenziwa ngumncedisi ofumane uqeqesho olugqibeleleyo 
malunga nezophando, eyakulwenza ngolwimi othe waIukhetha. Intloko yoluphando 
yiyo eyakulawula yongamele koluphando. Uyakunikwa ithuba lokubuza imibuzo 
phambi kokuba luqhutywe udliwano-ndlebe, nangelixesha luqhutwayo naxa sele 
lugqityiwe. Ukuncedisa koluphando, nokuqinisekisa okokuba impendulo oyakuthi 
uzinike ziyashicilelwa ngendlela efanelekileyo kuma cwecwe ayakuthl asetyenziswe 
kuphela kwiinjongo zoluphando. 
Nceda wazi ukuba inxaxheba oyithabathayo uyenza ngokuzithadela kwaye naluphina 
ulwazi esilufumeneyo kuwe nakwezinye izigulana ezinesifo sephepha ngelixesha 
loluphando luyakubayimfihlelo eqinisekisiweyo. Ukungafuni kwakho ukwaziwa 
kuyakukhuselwa. Ngako oko, igama lakho lokwenyani alisayi kusetyenziswa nanini 
na koluqokelelo lolwazi okanye kwingxelo ebhaliweyo, endaweni yoko wena kunye 
nawuphina umntu nendawo zokuhlalaezibandakanyekayo ziyakunikwa amagama 
angengawo la anikiweyo aze asetyenziswe kuzo zonke ingxelo ezenziwa ngomlomo 
nezibhaliweyo zashicilelwa. 
Ukwanalo nelungelo lokurhoxa koluphando nangaliphina ixesha, kwaye ukurhoxa 
kwakho akusayi kuchaphazela ngendlela engeyiyo uneedo olufumanayo eldiniki. 
Kwangokunjalo abasebenzi base ldiniki bazisiwe ngokupheleleyo ngoluphando 
kwaye balindeleke oko kuba babeyinxalenye yo'luphando ngeyona ndlela 
esemthethweni nesesikweni. 
Imvume yokuqhuba oluphando ifumaneke kwi Yunivesiti yase Kapa (VCT) kwisebe 
lezempilo. Kwakhona imvume yoluphando iphinde yanikezelwa ngabasemagunyeni 
abaphathelele kwicala lezempilo kwi dolophu yase Kapa. IYunivesithi yase Kapa, 
icandelo lezempilo kwidolophu yase Kapa kwakunye naba xhasi-mali ababini 
abangaba, IYunivesithi yase Ntshona Koloni (UWC), kunye nesiselco sophando 
lwamazwe jikelele (National Research Foundation) bayaqonda ukuba iziphumo 
zoluphando nezinto ezithi ziluquke ziyakushicilelwa kuma phepha ndaba (journals) 
obuchule nobugcisa. Impendulo ngokubanzi iyakunikezelwa kubaphathi becandelo 
lezempilo besixeko sase Kapa nabasebenzi abaphathelele kweze mpilo, nengcebiso 
ziyakunikwa ngoku phathelele kwizinto eziIungileyo nezingamasolotya enkqubo 
yonyango nokhuselo lwesifo sephepha. 
Okokugqibela, ndiyathemba okokuba niyakuziva nikhululekile ukubuza imibuzo 
yengcaciso nangaliphi na ixesha lale ntsebenziswano. Ungatsalela intloko yezophando 
kwezinombolo zingezantsi xa ufuna ukuxoxa nokuba ngowuphina umba wenkqubo 
yezophando. 
Ozithobileyo 
ASSOCIATE PROFESSOR PAMELA NAIDOO 
PRINCIPAL INVESTIGATOR 
Cell: 083 776 11 44 
Office: 959 2835/959 2283 
IFOMU YEMVUMEL W ANO EY AZISIWEYO 
Mna, ----------------------------, ndiyasiqonda isizathu sokwenziwa koluphando 
namanqanaba alo. 
Ndiwmile ukuthatha inxaxheba ngokuzithandela. Ngaphaya koko, ndiyaqonda 
kakuhle ukuba ndinalo ilungelo lokurhoxa koluphando nangaliphi ixesha. 
Umtyikityo womthathi-nxaxneba: Umhla: 
Umtyikityo womncedisi phando: Umhla: 
Appendix Two 
Participant Number: __ 
Please note that all information contained in this questionnaire will solely be used for the 
purposes of this research project and will remain strictly confidential. 
Please tick '" the box containing the correct infoIlllation. 
Part A 
AI. What is your sex? 
Male 
Female 
A2. What is your age in years? 
A3. What are your contact details? 
A4. What is your home language? 
English I 
Afrikaans 2 
Xhosa 3 
isiZulu 4 
If other (please specifY): ________ _ 
A5. In which residential area do you live? 
A6. What type of transport did you take to get to the clinic? 
Public Private 
A 7. Who lives with you? Where applicable please fill in the number of members per 
category. 
Example: If you have two brothers living with you. 
I Brotherls I 2 I 
I 
Participant Nmnbe:r: _ 
Mother Wife Mother-in-law 0 Father Partner Father-in-law 
Sister/s Son/s Cousinls 
Brother/s Daughter/s Friends 
Husband Grandmother If other please 
specify: 
AS. What is your relationship status? 
Sin Ie 1 
Married 
Divorced 3 
Widowed 4 
Living with a partner 5 
If other (please specify): ________ _ 
I A9. Dl YOj have dependant children living in your home? 
Yes 1 
No 2 
If yes, please specify the number of dependant children 
I I 
If yes, please specify the number of dependants 
I I 
AIO. What is your highest educational qualification? 
Below Grade 4 (Std 2) 1 T echinikon diploma 6 
Between Grade 4-7 (Std 2-5) 2 T echinikon degree 7 
Between Grade S-IO(Std 6-9) 3 Postgraduate diploma/degree 8 
Completed Matric 4 Masters degree 9 
Undergraduate degree 15 Doctoral degree 10 
If other (please specify): ________ _ 
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Participant Number: _ 
All. Are you currently employed/working? I ~~s I; I 
A13 What is your total household income after deductions? 
Less than R 2 500 1 
Between R 2 500- R5 000 2 
Between R 5 000 - R 7 500 3 
Between R 7 500 - RIO 000 4 
Between Rl 0 OO~ R12 500 5 
Between R12 500- R15 000 6 
Between R 15 000 and over 7 
A14. Do you practice a particular religion? Jfyes, are you: 
Moslem 
Christian 
African Traditional 
Other 
A15. Have you converted from another religion? If yes, please state when did this 
happen, and why you decided to convert? 
A16. Do you receive any financial aid from the government? If yes, please specify. 
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Participant Number: __ 
PartB 
How long have you been living with Tuberculosis (TB)? 
I I 
Does anyone else living in your home also have TB? 
Did they have TB in the past? ____ If yes, how long ago was this? ___ _ 
Other than TB, do you have any other existing physical or mental health problems? 
I ~:s I ~ I 
If yes, please specify:. ____________ _ 
What medication has been prescribed to you since your diagnosis? 
Please specify: ___________ _ 
Oth th er 'bed ed' ti what th an your prescn m lca on, 0 erm ed' 'nI b tan d you use? lcatlO su s ce 0 
Alcohol 1 Painkillers 4 
Marijuana 2 Cocaine 5 
Tik 3 Heroine 6 
If other (please specify): ________ _ 
Have you been for any other form of health care, such as traditional healing? __ 
If yes, were you given medication by the healer? __ _ 
How much did you pay the healer? ____ _ 
What do you do in your leisure/spare time? 
4 
Participant Number: _ 
Lonke ulwazi olakuthi lufumaneke ngalemibuzo ozakuthi uyiphendule 
luyakusetyenziswa kuphela kwiinjongo zoluphando. futhi luyakuba yimfihlelo 
eqinisekisiweyo. 
Fakela uphawu v ebhokisini. 
Isahlulo A 
AI. Chaza isini sakho? 
A2. Buthini ubudala bakho ngeminyaka? 
A3. Chaza inkcukacha zakho zonxibelelwano? 
A4. Chaza ulwimi lakho lwenkobe? 
isiZulu 
Ukuba kokho olunye nceda uchaze ________ _ 
AS. Uhlala kowuphi ummandla? 
A6. Chaza uhlobo lwesithu1hi othe wasisebezisa ukuza kwakho ekliniki? 
Esika wanke-wanke Esabucala okanye esakho 
A7. Uhlala nabani? Fakela inani lamalungu kuluhlu ngalinye. 
Umzekelo: Ukuba uhlala nabantakwenu ababini. 
I Umlabalntakwenu I 2 I 
I 
Participant Number: _ 
IMama Umfuzi Ma.zalalMkhwezi 
! Tata Umlingane Bawoza1alMkhwe 
i U/oo/dade U/oo/nyana Umlabalzala 
• Umlabalntakwethu I1ii/intombi Isilizilhlobo 
I Umyeni Makhulu Ukubakukho 
abangabanye nceda 
uchaze: 
A8. Sithini isimo sakho? 
Uwukatshati I 
Utshatile 2 
Ubutshatile 3 
wohlukana 
Umhlolo/mhlolokazi 4 
Uhlala nomlingane 5 
Ukuba kukho engenye nceda uchaze: ________ _ 
I A9
y 
Innbal kuhlro abantwana abaxhomokek:e kuwe ohIaIa naba ? 
Ewe I 
Ha i 2 
Ukuba kunjalo chaza inani labantwna abaxhomekeke kuwe 
I I 
Ukuba kunjalo chaza inani labantu abaxhomekeke kuwe 
I I 
AIO. Chaza ibanga eliphezulu lemfundo oliphumeleleyo? 
Ngaphantsi ko Greyidi 1 T echinikon diploma 
4(lbanga 2) 
Ngaphantsi kuka Greyidi 4-7 2 T echinikon degree 7 
(Ibanga 2-5) 
Ngaphansti kuka Greyidi 8- 3 Postgraduate diploma/degree 8 
10('"' 6-9) 
Uphumelele Imatriki 4 Masters degree 9 
Undergraduate degree 5 Doctoral degree 10 
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Participant Nmnber: _ 
Ukuba kukho engenye nceda uchaze ________ _ 
All. Ingaba uqashiwe/ uyasebenza? 
I:;'~ I 
Al3. Uthini umvuzo wekhaya uwonke emva kokutsalelwa? 
Ngaphantsi R 2 500 1 
Phakathi R 2 500- R5 000 2 
Phakathi R 5 000 - R 7 500 3 
Phakathi R 7 500 - RIO 000 4 
Phakathi RIO 000- R12 500 5 
Phakathi R12 500- R15 000 6 
Phakathi R 15 000 and over 7 
A14. Unalo uhlobo oluthile lwenkolo olulandelayo? Ukuba unalo ingaba ulandela: 
Muslimu 
Ubukris1u 
Inkolo yakwantu 
Engenye 
A15. Ingaba uguqukele kwenye inkolo? Ukuba kunjalo yenzeka nini. kutheni wagqiba 
ekubeni uguquke ? 
A16. Ingaba uyalufumana uncedo lwemali oluvela kurhulumente? Ukuba kunjalo chaza 
ucaClse. 
3 
Participant Number: __ 
Isahlulo B 
Uhleli ixesha elingakanani uphila nesifo sephepha (TB)? 
Wawukhe wanas.o esisifo kwilixa elidlulileyo? 
Ingaba kukho omnye umntu ohlala ekhayeni lakho onesifo sephepha? 
Babekhe banayo iTB kwilixa elidlulileyo? ____ Ukuba kunjalo kwakunini? 
Ngawaphi amayeza owanikwayo oko wafunyaniswa unesi sigulo? 
Ncedauchrure ____________ ___ 
N h dl kwam ~gapl an e ayezaowan h' , ebenzisayo? VO ngawaPJ 1 amanye amayeza mto OylS 
Utywala 1 Izibulala-ntlungu 4 
Intsango 2 Cocaine 5 
Tik 3 Heroine 6 
Ukuba kukho enye nceda uchrure _________ _ 
Ingaba wakhe wakolunye ulondolozo lwezempilo. olunje ngonyango lwesintu? __ 
Ukuba kunjalo. ingaba wanikwa amayeza yinyangi? __ _ 
Wayihlawula malini inyangi? ____ _ 
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Appendix Three 
APPENDIX THREE 
INTERVIEW GUIDE 
1. Tell me about the time you were first told that you have lB. How do you get think 
you got infected? 
2. Tell me how much you know about lB? 
3. What was happening in your life at the time you were diagnosed with lB? 
4. What is your experience of being a person with lB? 
5. What is your experience of taking the treatment that the nurses in the clinic give you? 
Have you been able to take your treatment exactly the way the nurses have advised you 
to? Are you getting advice and/or treatment from anyone else besides the nurses and 
doctors that treat you in the clinic? 
6. Have you been asked by the nurses whether you would like to have an HIV test? 
Would you mind telling me if you agreed to have the test? 
